| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein kinase activity | PIKFYVE TNNI3K ERBB2 FLT1 ERBB4 AATK RPS6KA4 CSF1R EGFR STK26 PRKAA1 RIPK4 PLK1 KIT EIF2AK2 STK24 PLK4 ALPK2 | 1.29e-10 | 600 | 89 | 18 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | PIKFYVE TNNI3K ERBB2 FLT1 ERBB4 PNKP AATK RPS6KA4 CSF1R EGFR STK26 PRKAA1 RIPK4 PLK1 KIT EIF2AK2 STK24 PLK4 ALPK2 | 2.48e-10 | 709 | 89 | 19 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | PIKFYVE TNNI3K ERBB2 FLT1 ERBB4 PNKP AATK RPS6KA4 CSF1R EGFR STK26 PRKAA1 RIPK4 PLK1 KIT EIF2AK2 STK24 PLK4 ALPK2 | 8.63e-10 | 764 | 89 | 19 | GO:0016301 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | PIKFYVE TNNI3K ERBB2 FLT1 ERBB4 PNKP AATK RPS6KA4 CSF1R EGFR STK26 PRKAA1 RIPK4 PLK1 KIT EIF2AK2 STK24 PLK4 ALPK2 | 2.44e-08 | 938 | 89 | 19 | GO:0016772 |
| GeneOntologyMolecularFunction | protein serine kinase activity | PIKFYVE TNNI3K AATK RPS6KA4 STK26 PRKAA1 RIPK4 PLK1 EIF2AK2 STK24 PLK4 ALPK2 | 7.34e-08 | 363 | 89 | 12 | GO:0106310 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | PIKFYVE TNNI3K AATK RPS6KA4 EGFR STK26 PRKAA1 RIPK4 PLK1 EIF2AK2 STK24 PLK4 ALPK2 | 8.71e-08 | 446 | 89 | 13 | GO:0004674 |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 2.74e-07 | 145 | 89 | 8 | GO:0004713 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 4.42e-07 | 65 | 89 | 6 | GO:0004714 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 2.18e-06 | 85 | 89 | 6 | GO:0019199 | |
| GeneOntologyMolecularFunction | growth factor binding | 6.25e-06 | 156 | 89 | 7 | GO:0019838 | |
| GeneOntologyMolecularFunction | epidermal growth factor receptor activity | 1.17e-04 | 4 | 89 | 2 | GO:0005006 | |
| GeneOntologyMolecularFunction | cadherin binding | 1.36e-04 | 339 | 89 | 8 | GO:0045296 | |
| GeneOntologyMolecularFunction | small GTPase binding | 5.80e-04 | 321 | 89 | 7 | GO:0031267 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.13e-03 | 46 | 89 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | GTPase binding | 1.13e-03 | 360 | 89 | 7 | GO:0051020 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | PIKFYVE FLT1 ERBB4 AATK CSF1R EGFR STK26 NBN KIT EIF2AK2 STK24 | 2.80e-09 | 228 | 86 | 11 | GO:0046777 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | GPLD1 CACNA1C ERBB2 FLT1 ERBB4 PNKP RAP1GAP RAPGEF6 CSF1R RGPD8 EGFR RGPD3 NBN PLK1 RGP1 KIT MTCH1 PHB1 | 1.90e-07 | 1028 | 86 | 18 | GO:0043085 |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | GPLD1 CACNA1C ERBB2 FLT1 ERBB4 PNKP RAP1GAP RAPGEF6 RPS6KA4 CSF1R RGPD8 EGFR RGPD3 NBN RIPK4 PLK1 RGP1 KIT EIF2AK2 MTCH1 PHB1 | 2.89e-07 | 1430 | 86 | 21 | GO:0044093 |
| GeneOntologyBiologicalProcess | intracellular protein transport | SORT1 NUP50 FLNA RGPD8 COPA WDR11 VPS13C RGPD3 STEEP1 VPS13A CTTN MTCH1 HSPA5 NUP153 RGPD5 | 3.72e-07 | 740 | 86 | 15 | GO:0006886 |
| GeneOntologyBiologicalProcess | protein localization to organelle | SORT1 PIKFYVE NUP50 FLNA ERBB2 ERBB4 RGPD8 VPS13C RGPD3 PRKAA1 VPS13A NBN PLK1 MTCH1 HSPA5 NUP153 DDX1 RGPD5 | 4.56e-07 | 1091 | 86 | 18 | GO:0033365 |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | ERBB2 FLT1 ERBB4 PNKP CSF1R RGPD8 EGFR RGPD3 NBN PLK1 KIT PHB1 | 8.78e-07 | 490 | 86 | 12 | GO:0051347 |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | SORT1 NUP50 FLNA RGPD8 VPS13C RGPD3 PRKAA1 VPS13A MTCH1 HSPA5 NUP153 RGPD5 | 1.48e-06 | 515 | 86 | 12 | GO:0072594 |
| GeneOntologyBiologicalProcess | cellular response to epidermal growth factor stimulus | 1.85e-06 | 49 | 86 | 5 | GO:0071364 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | SORT1 COL4A2 ERBB2 FLT1 ERBB4 RAP1GAP EGFR RBBP4 RBBP7 MARS1 IREB2 CORO1B HSPA5 RYR1 DNMT1 | 2.10e-06 | 850 | 86 | 15 | GO:0071363 |
| GeneOntologyBiologicalProcess | intracellular transport | SORT1 PIKFYVE NUP50 FLNA SFPQ RGPD8 COPA WDR11 VPS13C PURA RGPD3 STEEP1 VPS13A KIF4A CTTN RGP1 MTCH1 HSPA5 NUP153 RGPD5 | 2.55e-06 | 1496 | 86 | 20 | GO:0046907 |
| GeneOntologyBiologicalProcess | response to epidermal growth factor | 3.02e-06 | 54 | 86 | 5 | GO:0070849 | |
| GeneOntologyBiologicalProcess | response to growth factor | SORT1 COL4A2 ERBB2 FLT1 ERBB4 RAP1GAP EGFR RBBP4 RBBP7 MARS1 IREB2 CORO1B HSPA5 RYR1 DNMT1 | 3.35e-06 | 883 | 86 | 15 | GO:0070848 |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 7.15e-06 | 405 | 86 | 10 | GO:0033674 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | ERBB2 FLT1 ERBB4 CSF1R RGPD8 EGFR RGPD3 NBN PLK1 KIT HERC5 PHB1 | 2.68e-05 | 686 | 86 | 12 | GO:0043549 |
| GeneOntologyBiologicalProcess | regulation of locomotion | GPLD1 FLNA FLT1 ERBB4 CSF1R EGFR RBBP4 RBBP7 STK26 LAMA2 CORO1B CTTN KIT STK24 HSPA5 TBC1D24 ATP5F1B | 2.87e-05 | 1327 | 86 | 17 | GO:0040012 |
| GeneOntologyBiologicalProcess | regulation of transferase activity | ERBB2 FLT1 ERBB4 PNKP CSF1R RGPD8 EGFR RGPD3 NBN PLK1 KIT HERC5 PHB1 | 2.95e-05 | 810 | 86 | 13 | GO:0051338 |
| GeneOntologyBiologicalProcess | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 3.44e-05 | 217 | 86 | 7 | GO:0051897 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | GPLD1 FLNA FLT1 ERBB4 CSF1R EGFR RBBP4 RBBP7 STK26 LAMA2 CORO1B KIT STK24 HSPA5 TBC1D24 ATP5F1B | 3.54e-05 | 1211 | 86 | 16 | GO:0030334 |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | FLNA PNKP EGFR VPS13C LPCAT3 NBN PLK1 EIF2AK2 STK24 HSPA5 TBC1D24 | 3.79e-05 | 598 | 86 | 11 | GO:0080135 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | PIKFYVE ERBB2 FLT1 ERBB4 AATK RPS6KA4 CSF1R RGPD8 EGFR RGPD3 PRKAA1 PLK1 KIT TBC1D24 | 4.85e-05 | 976 | 86 | 14 | GO:0018193 |
| GeneOntologyBiologicalProcess | Golgi to endosome transport | 5.46e-05 | 18 | 86 | 3 | GO:0006895 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | GPLD1 ERBB2 FLT1 ERBB4 CSF1R RGPD8 EGFR RGPD3 PRKAA1 NBN PLK1 KIT PHB1 | 6.83e-05 | 879 | 86 | 13 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | GPLD1 ERBB2 FLT1 ERBB4 CSF1R RGPD8 EGFR RGPD3 PRKAA1 NBN PLK1 KIT PHB1 | 6.83e-05 | 879 | 86 | 13 | GO:0010562 |
| GeneOntologyBiologicalProcess | regulation of cell motility | GPLD1 FLNA FLT1 ERBB4 CSF1R EGFR RBBP4 RBBP7 STK26 LAMA2 CORO1B KIT STK24 HSPA5 TBC1D24 ATP5F1B | 6.87e-05 | 1280 | 86 | 16 | GO:2000145 |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 7.58e-05 | 20 | 86 | 3 | GO:0006607 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | SORT1 COL4A2 GPLD1 ERBB2 FLT1 ERBB4 CSF1R EGFR RBBP4 RBBP7 PRKAA1 VPS13A KIT HSPA5 RYR1 | 1.05e-04 | 1186 | 86 | 15 | GO:0007167 |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 1.34e-04 | 362 | 86 | 8 | GO:0034504 | |
| GeneOntologyBiologicalProcess | protein targeting | 1.65e-04 | 373 | 86 | 8 | GO:0006605 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 1.66e-04 | 195 | 86 | 6 | GO:0006606 | |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 1.70e-04 | 5 | 86 | 2 | GO:0045053 | |
| GeneOntologyBiologicalProcess | ERBB2-ERBB4 signaling pathway | 1.70e-04 | 5 | 86 | 2 | GO:0038135 | |
| GeneOntologyBiologicalProcess | ERBB2 signaling pathway | 1.90e-04 | 27 | 86 | 3 | GO:0038128 | |
| GeneOntologyBiologicalProcess | import into nucleus | 1.96e-04 | 201 | 86 | 6 | GO:0051170 | |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | 2.01e-04 | 202 | 86 | 6 | GO:0006937 | |
| GeneOntologyBiologicalProcess | microvillus assembly | 2.13e-04 | 28 | 86 | 3 | GO:0030033 | |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | GPLD1 FLNA FLT1 ERBB4 CSF1R EGFR CTTN KIT HSPA5 TBC1D24 ATP5F1B | 2.55e-04 | 742 | 86 | 11 | GO:0040017 |
| GeneOntologyBiologicalProcess | dendritic transport of ribonucleoprotein complex | 2.55e-04 | 6 | 86 | 2 | GO:0098961 | |
| GeneOntologyBiologicalProcess | dendritic transport of messenger ribonucleoprotein complex | 2.55e-04 | 6 | 86 | 2 | GO:0098963 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | SORT1 COL4A2 GPLD1 ERBB2 FLT1 ERBB4 CSF1R EGFR PRKAA1 VPS13A KIT | 2.70e-04 | 747 | 86 | 11 | GO:0007169 |
| GeneOntologyBiologicalProcess | circulatory system development | COL4A2 GPLD1 CACNA1C FLNA ERBB2 FLT1 ERBB4 ALDH1A2 EGFR WDR11 KIT ALPK2 RYR1 CEMIP2 DNMT1 ATP5F1B | 2.72e-04 | 1442 | 86 | 16 | GO:0072359 |
| GeneOntologyBiologicalProcess | protein localization to cell leading edge | 3.56e-04 | 7 | 86 | 2 | GO:1902463 | |
| GeneOntologyBiologicalProcess | microvillus organization | 3.81e-04 | 34 | 86 | 3 | GO:0032528 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | 3.89e-04 | 780 | 86 | 11 | GO:0042327 | |
| GeneOntologyBiologicalProcess | cytosolic transport | 4.13e-04 | 150 | 86 | 5 | GO:0016482 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine phosphorylation | 4.34e-04 | 327 | 86 | 7 | GO:0018108 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine modification | 4.51e-04 | 329 | 86 | 7 | GO:0018212 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | FLNA RAP1GAP RAPGEF6 WDR11 STK26 CAPZB CTTN KIT PLK4 TBC1D24 | 4.69e-04 | 670 | 86 | 10 | GO:0120031 |
| GeneOntologyBiologicalProcess | ERBB2-EGFR signaling pathway | 4.73e-04 | 8 | 86 | 2 | GO:0038134 | |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 4.93e-04 | 334 | 86 | 7 | GO:0051896 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | SORT1 COL4A2 ERBB2 FLT1 RAP1GAP CSF1R EGFR RBBP4 RBBP7 NBN CORO1B KIT ALPK2 DNMT1 | 4.94e-04 | 1220 | 86 | 14 | GO:0051093 |
| GeneOntologyBiologicalProcess | cell projection assembly | FLNA RAP1GAP RAPGEF6 WDR11 STK26 CAPZB CTTN KIT PLK4 TBC1D24 | 5.57e-04 | 685 | 86 | 10 | GO:0030031 |
| GeneOntologyBiologicalProcess | positive regulation of cell migration | 5.96e-04 | 691 | 86 | 10 | GO:0030335 | |
| GeneOntologyBiologicalProcess | double-strand break repair via alternative nonhomologous end joining | 6.07e-04 | 9 | 86 | 2 | GO:0097681 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 6.07e-04 | 9 | 86 | 2 | GO:0033133 | |
| GeneOntologyBiologicalProcess | symbiont entry into host cell | 7.10e-04 | 169 | 86 | 5 | GO:0046718 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 7.52e-04 | 259 | 86 | 6 | GO:0051651 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 7.57e-04 | 10 | 86 | 2 | GO:1903301 | |
| GeneOntologyBiologicalProcess | lamellipodium organization | 7.84e-04 | 99 | 86 | 4 | GO:0097581 | |
| GeneOntologyBiologicalProcess | symbiont entry into host | 8.52e-04 | 176 | 86 | 5 | GO:0044409 | |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | 8.62e-04 | 725 | 86 | 10 | GO:2000147 | |
| GeneOntologyBiologicalProcess | cellular response to iron ion | 9.22e-04 | 11 | 86 | 2 | GO:0071281 | |
| GeneOntologyBiologicalProcess | ERBB4 signaling pathway | 9.22e-04 | 11 | 86 | 2 | GO:0038130 | |
| GeneOntologyBiologicalProcess | regulation of system process | 9.46e-04 | 734 | 86 | 10 | GO:0044057 | |
| GeneOntologyBiologicalProcess | cellular response to starvation | 1.06e-03 | 185 | 86 | 5 | GO:0009267 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 1.08e-03 | 382 | 86 | 7 | GO:0043491 | |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | FLNA ERBB2 ERBB4 CSF1R EGFR PRKAA1 CTTN PLK1 KIT EIF2AK2 HSPA5 DNMT1 PHB1 | 1.09e-03 | 1171 | 86 | 13 | GO:0043069 |
| GeneOntologyBiologicalProcess | midgut development | 1.10e-03 | 12 | 86 | 2 | GO:0007494 | |
| GeneOntologyBiologicalProcess | positive regulation of dendritic cell cytokine production | 1.10e-03 | 12 | 86 | 2 | GO:0002732 | |
| GeneOntologyBiologicalProcess | hematopoietic stem cell migration | 1.10e-03 | 12 | 86 | 2 | GO:0035701 | |
| GeneOntologyBiologicalProcess | protein targeting to vacuole | 1.12e-03 | 49 | 86 | 3 | GO:0006623 | |
| GeneOntologyBiologicalProcess | regulation of transcription by RNA polymerase I | 1.19e-03 | 50 | 86 | 3 | GO:0006356 | |
| GeneOntologyBiologicalProcess | maintenance of protein location | 1.24e-03 | 112 | 86 | 4 | GO:0045185 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | PIKFYVE FLNA RAP1GAP SACS PRKAA1 CAPZB CTTN PLK1 KIT EIF2AK2 PLK4 HSPA5 TBC1D24 | 1.25e-03 | 1189 | 86 | 13 | GO:0044087 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | PIKFYVE FLNA PNKP SFPQ CSF1R VPS13C PRKAA1 CAPZB NBN CORO1B CTTN PLK1 PLK4 TBC1D24 | 1.25e-03 | 1342 | 86 | 14 | GO:0033043 |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | FLNA ERBB2 FLT1 ERBB4 ALDH1A2 CSF1R EGFR PURA PRKAA1 NBN KIT DNMT1 PHB1 | 1.26e-03 | 1190 | 86 | 13 | GO:0008284 |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.30e-03 | 13 | 86 | 2 | GO:0033131 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum membrane organization | 1.30e-03 | 13 | 86 | 2 | GO:0090158 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | GPLD1 CACNA1C FLNA ALDH1A2 EGFR RBBP7 PRKAA1 EIF2AK2 DDX1 RYR1 DNMT1 PHB1 | 1.32e-03 | 1048 | 86 | 12 | GO:0014070 |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.35e-06 | 20 | 88 | 4 | GO:0042405 | |
| GeneOntologyCellularComponent | somatodendritic compartment | SORT1 CACNA1C FLNA ERBB4 RAP1GAP SFPQ TRPM5 CSF1R COPA SACS PURA PRKAA1 VPS13A CAPZB LAMA2 IREB2 CTTN HSPA5 | 2.93e-06 | 1228 | 88 | 18 | GO:0036477 |
| GeneOntologyCellularComponent | cell body | SORT1 CACNA1C FLNA ERBB4 RAP1GAP TRPM5 CSF1R COPA PURA PRKAA1 STEEP1 VPS13A CAPZB IREB2 HSPA5 | 7.08e-06 | 929 | 88 | 15 | GO:0044297 |
| GeneOntologyCellularComponent | neuronal cell body | SORT1 CACNA1C FLNA ERBB4 RAP1GAP TRPM5 CSF1R COPA PURA PRKAA1 VPS13A CAPZB IREB2 HSPA5 | 9.74e-06 | 835 | 88 | 14 | GO:0043025 |
| GeneOntologyCellularComponent | dendrite | SORT1 CACNA1C FLNA ERBB4 RAP1GAP SFPQ TRPM5 SACS PURA PRKAA1 CAPZB LAMA2 CTTN HSPA5 | 1.32e-05 | 858 | 88 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | SORT1 CACNA1C FLNA ERBB4 RAP1GAP SFPQ TRPM5 SACS PURA PRKAA1 CAPZB LAMA2 CTTN HSPA5 | 1.36e-05 | 860 | 88 | 14 | GO:0097447 |
| GeneOntologyCellularComponent | annulate lamellae | 2.54e-05 | 14 | 88 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | SORT1 PIKFYVE FLNA ERBB2 ALDH1A2 AATK RGPD8 EGFR STK26 RGPD3 CORO1B EIF2AK2 RYR1 HERC5 | 3.38e-05 | 934 | 88 | 14 | GO:0048471 |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 5.62e-05 | 18 | 88 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear pore | 6.80e-05 | 101 | 88 | 5 | GO:0005643 | |
| GeneOntologyCellularComponent | NURF complex | 3.63e-04 | 7 | 88 | 2 | GO:0016589 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 4.83e-04 | 8 | 88 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | mitochondrial outer membrane | 5.44e-04 | 241 | 88 | 6 | GO:0005741 | |
| GeneOntologyCellularComponent | inclusion body | 5.69e-04 | 90 | 88 | 4 | GO:0016234 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 7.71e-04 | 10 | 88 | 2 | GO:0044614 | |
| GeneOntologyCellularComponent | organelle outer membrane | 1.16e-03 | 279 | 88 | 6 | GO:0031968 | |
| GeneOntologyCellularComponent | outer membrane | 1.21e-03 | 281 | 88 | 6 | GO:0019867 | |
| GeneOntologyCellularComponent | neuromuscular junction | 1.29e-03 | 112 | 88 | 4 | GO:0031594 | |
| GeneOntologyCellularComponent | ISWI-type complex | 1.54e-03 | 14 | 88 | 2 | GO:0031010 | |
| GeneOntologyCellularComponent | focal adhesion | 2.28e-03 | 431 | 88 | 7 | GO:0005925 | |
| GeneOntologyCellularComponent | FAR/SIN/STRIPAK complex | 2.29e-03 | 17 | 88 | 2 | GO:0090443 | |
| GeneOntologyCellularComponent | CHD-type complex | 2.29e-03 | 17 | 88 | 2 | GO:0090545 | |
| GeneOntologyCellularComponent | ESC/E(Z) complex | 2.29e-03 | 17 | 88 | 2 | GO:0035098 | |
| GeneOntologyCellularComponent | NuRD complex | 2.29e-03 | 17 | 88 | 2 | GO:0016581 | |
| GeneOntologyCellularComponent | organelle envelope | SORT1 NUP50 RGPD8 EGFR VPS13C DNAJC11 RGPD3 VPS13A FUNDC2 MTCH1 NUP153 ATP5F1B PHB1 RGPD5 | 2.59e-03 | 1435 | 88 | 14 | GO:0031967 |
| GeneOntologyCellularComponent | cell-substrate junction | 2.66e-03 | 443 | 88 | 7 | GO:0030055 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 3.49e-03 | 21 | 88 | 2 | GO:0106068 | |
| GeneOntologyCellularComponent | nuclear membrane | 3.57e-03 | 349 | 88 | 6 | GO:0031965 | |
| GeneOntologyCellularComponent | dendritic shaft | 3.77e-03 | 74 | 88 | 3 | GO:0043198 | |
| GeneOntologyCellularComponent | Sin3-type complex | 3.83e-03 | 22 | 88 | 2 | GO:0070822 | |
| GeneOntologyCellularComponent | axon | CACNA1C FLNA RAP1GAP COPA SACS PRKAA1 KIF4A IREB2 CTTN TBC1D24 | 4.20e-03 | 891 | 88 | 10 | GO:0030424 |
| MousePheno | embryonic lethality prior to organogenesis | PIKFYVE PNKP SFPQ RGPD8 EGFR RBBP4 RGPD3 GART UGDH NBN SRBD1 CTTN PLK1 RGP1 KIT PLK4 HSPA5 NUP153 DDX1 ATP5F1B PHB1 | 6.52e-07 | 1204 | 74 | 21 | MP:0013292 |
| MousePheno | embryonic lethality prior to tooth bud stage | PIKFYVE PNKP SFPQ RGPD8 EGFR RBBP4 RGPD3 GART UGDH NBN SRBD1 CTTN PLK1 RGP1 KIT PLK4 HSPA5 NUP153 DDX1 DNMT1 ATP5F1B PHB1 | 1.56e-06 | 1383 | 74 | 22 | MP:0013293 |
| MousePheno | abnormal brain size | PIKFYVE GPLD1 PNKP AATK SELENBP1 EGFR PURA STEEP1 LAMA2 KIF4A HSPA5 | 4.11e-06 | 375 | 74 | 11 | MP:0000771 |
| MousePheno | abnormal spinal cord morphology | 1.53e-05 | 278 | 74 | 9 | MP:0000955 | |
| MousePheno | abnormal sensory ganglion morphology | 2.11e-05 | 221 | 74 | 8 | MP:0000960 | |
| MousePheno | embryonic lethality prior to tooth bud stage, complete penetrance | PIKFYVE RGPD8 EGFR RBBP4 RGPD3 UGDH NBN CTTN PLK1 KIT PLK4 HSPA5 DNMT1 PHB1 | 4.97e-05 | 779 | 74 | 14 | MP:0014257 |
| MousePheno | embryonic lethality before implantation, complete penetrance | 9.70e-05 | 203 | 74 | 7 | MP:0011094 | |
| MousePheno | abnormal spleen weight | 1.16e-04 | 361 | 74 | 9 | MP:0004951 | |
| MousePheno | decreased brain size | 1.61e-04 | 295 | 74 | 8 | MP:0000774 | |
| MousePheno | embryonic lethality prior to organogenesis, complete penetrance | PIKFYVE RGPD8 EGFR RBBP4 RGPD3 UGDH NBN CTTN PLK1 KIT PLK4 HSPA5 PHB1 | 1.84e-04 | 772 | 74 | 13 | MP:0014259 |
| MousePheno | abnormal trigeminal ganglion morphology | 2.01e-04 | 55 | 74 | 4 | MP:0001092 | |
| MousePheno | abnormal glossopharyngeal nerve morphology | 2.04e-04 | 22 | 74 | 3 | MP:0001073 | |
| MousePheno | absent myocardial trabeculae | 2.04e-04 | 22 | 74 | 3 | MP:0000293 | |
| MousePheno | abnormal nervous system development | PIKFYVE NUP50 ERBB2 ERBB4 ALDH1A2 CSF1R EGFR WDR11 RBBP4 PURA STEEP1 LAMA2 KIT PLK4 HSPA5 TBC1D24 DNMT1 | 2.41e-04 | 1257 | 74 | 17 | MP:0003861 |
| MousePheno | embryonic lethality before implantation | 2.87e-04 | 242 | 74 | 7 | MP:0006204 | |
| MousePheno | abnormal cranial ganglia morphology | 3.24e-04 | 175 | 74 | 6 | MP:0001081 | |
| Domain | Protein_kinase_ATP_BS | TNNI3K ERBB2 FLT1 ERBB4 AATK RPS6KA4 CSF1R EGFR STK26 PRKAA1 PLK1 KIT EIF2AK2 STK24 PLK4 | 2.56e-10 | 379 | 88 | 15 | IPR017441 |
| Domain | PROTEIN_KINASE_ATP | TNNI3K ERBB2 FLT1 ERBB4 AATK RPS6KA4 CSF1R EGFR STK26 PRKAA1 RIPK4 PLK1 KIT EIF2AK2 STK24 PLK4 | 3.90e-10 | 459 | 88 | 16 | PS00107 |
| Domain | Kinase-like_dom | TNNI3K ERBB2 FLT1 ERBB4 AATK RPS6KA4 CSF1R EGFR STK26 PRKAA1 RIPK4 PLK1 KIT EIF2AK2 STK24 PLK4 ALPK2 | 5.21e-10 | 542 | 88 | 17 | IPR011009 |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 9.65e-10 | 138 | 88 | 10 | IPR001245 | |
| Domain | Prot_kinase_dom | TNNI3K ERBB2 FLT1 ERBB4 AATK RPS6KA4 CSF1R EGFR STK26 PRKAA1 RIPK4 PLK1 KIT EIF2AK2 STK24 PLK4 | 9.77e-10 | 489 | 88 | 16 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | TNNI3K ERBB2 FLT1 ERBB4 AATK RPS6KA4 CSF1R EGFR STK26 PRKAA1 RIPK4 PLK1 KIT EIF2AK2 STK24 PLK4 | 1.10e-09 | 493 | 88 | 16 | PS50011 |
| Domain | Pkinase_Tyr | 9.74e-09 | 129 | 88 | 9 | PF07714 | |
| Domain | PROTEIN_KINASE_TYR | 1.80e-08 | 97 | 88 | 8 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.80e-08 | 97 | 88 | 8 | IPR008266 | |
| Domain | Ran_BP1 | 2.21e-07 | 12 | 88 | 4 | PF00638 | |
| Domain | RANBD1 | 2.21e-07 | 12 | 88 | 4 | PS50196 | |
| Domain | RanBD | 3.18e-07 | 13 | 88 | 4 | SM00160 | |
| Domain | Ran_bind_dom | 3.18e-07 | 13 | 88 | 4 | IPR000156 | |
| Domain | Tyr_kinase_EGF/ERB/XmrK_rcpt | 4.03e-07 | 4 | 88 | 3 | IPR016245 | |
| Domain | WD40_repeat_CS | 1.05e-06 | 164 | 88 | 8 | IPR019775 | |
| Domain | GF_recep_IV | 2.00e-06 | 6 | 88 | 3 | PF14843 | |
| Domain | GF_recep_IV | 2.00e-06 | 6 | 88 | 3 | IPR032778 | |
| Domain | Furin-like | 3.49e-06 | 7 | 88 | 3 | PF00757 | |
| Domain | Rcpt_L-dom | 3.49e-06 | 7 | 88 | 3 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 3.49e-06 | 7 | 88 | 3 | IPR006211 | |
| Domain | Recep_L_domain | 3.49e-06 | 7 | 88 | 3 | PF01030 | |
| Domain | - | 3.49e-06 | 7 | 88 | 3 | 3.80.20.20 | |
| Domain | TyrKc | 3.66e-06 | 88 | 88 | 6 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 3.66e-06 | 88 | 88 | 6 | IPR020635 | |
| Domain | - | SORT1 EML5 SELENBP1 COPA WDR11 RBBP4 RBBP7 EML6 KCTD3 CORO1B | 3.74e-06 | 333 | 88 | 10 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | SORT1 EML5 SELENBP1 COPA WDR11 RBBP4 RBBP7 EML6 KCTD3 CORO1B | 3.94e-06 | 335 | 88 | 10 | IPR015943 |
| Domain | Tyr_kinase_rcpt_3_CS | 5.56e-06 | 8 | 88 | 3 | IPR001824 | |
| Domain | RECEPTOR_TYR_KIN_III | 5.56e-06 | 8 | 88 | 3 | PS00240 | |
| Domain | Grip | 1.62e-05 | 11 | 88 | 3 | SM00755 | |
| Domain | GRIP | 1.62e-05 | 11 | 88 | 3 | PF01465 | |
| Domain | GRIP_dom | 2.16e-05 | 12 | 88 | 3 | IPR000237 | |
| Domain | GRIP | 2.16e-05 | 12 | 88 | 3 | PS50913 | |
| Domain | WD40 | 3.86e-05 | 268 | 88 | 8 | SM00320 | |
| Domain | WD40_repeat | 4.29e-05 | 272 | 88 | 8 | IPR001680 | |
| Domain | WD_REPEATS_1 | 5.00e-05 | 278 | 88 | 8 | PS00678 | |
| Domain | WD_REPEATS_2 | 5.13e-05 | 279 | 88 | 8 | PS50082 | |
| Domain | WD_REPEATS_REGION | 5.13e-05 | 279 | 88 | 8 | PS50294 | |
| Domain | PROTEIN_KINASE_ST | 5.19e-05 | 362 | 88 | 9 | PS00108 | |
| Domain | GART_AS | 6.56e-05 | 3 | 88 | 2 | IPR001555 | |
| Domain | VPS13 | 6.56e-05 | 3 | 88 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 6.56e-05 | 3 | 88 | 2 | PF16910 | |
| Domain | VPS13 | 6.56e-05 | 3 | 88 | 2 | PF16908 | |
| Domain | VPS13_N2 | 6.56e-05 | 3 | 88 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 6.56e-05 | 3 | 88 | 2 | IPR031642 | |
| Domain | CAF1C_H4-bd | 6.56e-05 | 3 | 88 | 2 | PF12265 | |
| Domain | GART | 6.56e-05 | 3 | 88 | 2 | PS00373 | |
| Domain | Histone-bd_RBBP4_N | 6.56e-05 | 3 | 88 | 2 | IPR022052 | |
| Domain | Furin_repeat | 7.84e-05 | 18 | 88 | 3 | IPR006212 | |
| Domain | FU | 7.84e-05 | 18 | 88 | 3 | SM00261 | |
| Domain | WD40_repeat_dom | 7.95e-05 | 297 | 88 | 8 | IPR017986 | |
| Domain | Apc4_WD40_dom | 1.09e-04 | 20 | 88 | 3 | IPR024977 | |
| Domain | ANAPC4_WD40 | 1.09e-04 | 20 | 88 | 3 | PF12894 | |
| Domain | VPS13_C | 1.31e-04 | 4 | 88 | 2 | PF16909 | |
| Domain | Formyl_trans_N | 1.31e-04 | 4 | 88 | 2 | PF00551 | |
| Domain | SHR-BD | 1.31e-04 | 4 | 88 | 2 | IPR009543 | |
| Domain | POLO_box | 1.31e-04 | 4 | 88 | 2 | PF00659 | |
| Domain | POLO_BOX | 1.31e-04 | 4 | 88 | 2 | PS50078 | |
| Domain | VPS13_C | 1.31e-04 | 4 | 88 | 2 | IPR031645 | |
| Domain | - | 1.31e-04 | 4 | 88 | 2 | 3.40.50.170 | |
| Domain | Formyl_transf_N | 1.31e-04 | 4 | 88 | 2 | IPR002376 | |
| Domain | SHR-BD | 1.31e-04 | 4 | 88 | 2 | PF06650 | |
| Domain | ATG_C | 2.17e-04 | 5 | 88 | 2 | PF09333 | |
| Domain | Cyt_c1_TM_anchor_C | 2.17e-04 | 5 | 88 | 2 | IPR021157 | |
| Domain | POLO_box_dom | 2.17e-04 | 5 | 88 | 2 | IPR000959 | |
| Domain | Autophagy-rel_C | 2.17e-04 | 5 | 88 | 2 | IPR015412 | |
| Domain | WD40 | 2.22e-04 | 259 | 88 | 7 | PF00400 | |
| Domain | Tyr_kinase_CSF1/PDGF_rcpt | 3.25e-04 | 6 | 88 | 2 | IPR016243 | |
| Domain | HELP | 3.25e-04 | 6 | 88 | 2 | PF03451 | |
| Domain | HELP | 3.25e-04 | 6 | 88 | 2 | IPR005108 | |
| Domain | Haem_d1 | 3.25e-04 | 6 | 88 | 2 | IPR011048 | |
| Domain | Pkinase | 4.32e-04 | 381 | 88 | 8 | PF00069 | |
| Domain | GCC2_Rab_bind | 4.54e-04 | 7 | 88 | 2 | IPR032023 | |
| Domain | Rab_bind | 4.54e-04 | 7 | 88 | 2 | PF16704 | |
| Domain | VPS13_N | 6.03e-04 | 8 | 88 | 2 | IPR026854 | |
| Domain | Chorein_N | 6.03e-04 | 8 | 88 | 2 | PF12624 | |
| Domain | - | 9.64e-04 | 10 | 88 | 2 | 1.10.220.60 | |
| Domain | Ser/Thr_kinase_AS | 1.48e-03 | 357 | 88 | 7 | IPR008271 | |
| Domain | S_TKc | 1.53e-03 | 359 | 88 | 7 | SM00220 | |
| Domain | N2O_reductase_N | 2.21e-03 | 15 | 88 | 2 | IPR011045 | |
| Domain | Ald_DH_CS_GLU | 2.52e-03 | 16 | 88 | 2 | IPR029510 | |
| Domain | Ald_DH_CS_CYS | 2.85e-03 | 17 | 88 | 2 | IPR016160 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 3.20e-03 | 18 | 88 | 2 | PS00687 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 3.20e-03 | 18 | 88 | 2 | PS00070 | |
| Domain | Ald_DH_C | 3.56e-03 | 19 | 88 | 2 | IPR016163 | |
| Domain | Ald_DH_N | 3.56e-03 | 19 | 88 | 2 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 3.56e-03 | 19 | 88 | 2 | IPR016161 | |
| Domain | - | 3.56e-03 | 19 | 88 | 2 | 3.40.605.10 | |
| Domain | Aldedh | 3.56e-03 | 19 | 88 | 2 | PF00171 | |
| Domain | Aldehyde_DH_dom | 3.56e-03 | 19 | 88 | 2 | IPR015590 | |
| Domain | - | 3.56e-03 | 19 | 88 | 2 | 3.40.309.10 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 4.23e-03 | 69 | 88 | 3 | IPR020636 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 1.25e-09 | 25 | 65 | 6 | M47934 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY | 2.17e-06 | 83 | 65 | 6 | M47961 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY | 3.27e-06 | 89 | 65 | 6 | M47963 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY | 3.97e-06 | 92 | 65 | 6 | M47927 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 5.19e-06 | 55 | 65 | 5 | MM14917 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 1.50e-05 | 11 | 65 | 3 | MM15478 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.10e-05 | 73 | 65 | 5 | MM14948 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 2.59e-05 | 13 | 65 | 3 | M27729 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 2.59e-05 | 13 | 65 | 3 | MM15320 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 3.28e-05 | 14 | 65 | 3 | MM14761 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 3.28e-05 | 14 | 65 | 3 | MM14531 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 3.32e-05 | 40 | 65 | 4 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 3.67e-05 | 41 | 65 | 4 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 4.04e-05 | 42 | 65 | 4 | MM15039 | |
| Pathway | PID_ERBB_NETWORK_PATHWAY | 4.09e-05 | 15 | 65 | 3 | M201 | |
| Pathway | REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS | 4.09e-05 | 15 | 65 | 3 | M27766 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 4.09e-05 | 15 | 65 | 3 | M27608 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 4.44e-05 | 43 | 65 | 4 | MM14609 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 5.02e-05 | 16 | 65 | 3 | M562 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 5.02e-05 | 16 | 65 | 3 | M570 | |
| Pathway | WP_RETINOBLASTOMA_GENE_IN_CANCER | 5.79e-05 | 90 | 65 | 5 | M39678 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 6.33e-05 | 47 | 65 | 4 | MM14939 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 6.43e-05 | 92 | 65 | 5 | MM14951 | |
| Pathway | REACTOME_SIGNALING_BY_PTK6 | 6.88e-05 | 48 | 65 | 4 | MM15479 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 7.46e-05 | 49 | 65 | 4 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 8.08e-05 | 50 | 65 | 4 | MM14610 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 8.70e-05 | 98 | 65 | 5 | M39830 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 8.74e-05 | 51 | 65 | 4 | MM15151 | |
| Pathway | WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA | 1.01e-04 | 20 | 65 | 3 | M39381 | |
| Pathway | REACTOME_SIGNALING_BY_PTK6 | 1.09e-04 | 54 | 65 | 4 | M29742 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 1.18e-04 | 55 | 65 | 4 | M47952 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 1.35e-04 | 22 | 65 | 3 | M26929 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.45e-04 | 58 | 65 | 4 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.45e-04 | 58 | 65 | 4 | MM14736 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 1.55e-04 | 23 | 65 | 3 | MM1480 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 1.55e-04 | 23 | 65 | 3 | M18719 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.78e-04 | 114 | 65 | 5 | MM15361 | |
| Pathway | KEGG_ENDOCYTOSIS | 1.82e-04 | 181 | 65 | 6 | M1519 | |
| Pathway | WP_FOCAL_ADHESION | 2.17e-04 | 187 | 65 | 6 | MM15913 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_IN_CANCER | 2.26e-04 | 26 | 65 | 3 | M29535 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 2.26e-04 | 26 | 65 | 3 | MM15501 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 2.26e-04 | 65 | 65 | 4 | MM15147 | |
| Pathway | PID_TELOMERASE_PATHWAY | 2.54e-04 | 67 | 65 | 4 | M105 | |
| Pathway | WP_FOCAL_ADHESION | 3.03e-04 | 199 | 65 | 6 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.03e-04 | 199 | 65 | 6 | M7253 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 3.14e-04 | 29 | 65 | 3 | M27756 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 3.72e-04 | 74 | 65 | 4 | M48006 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 3.84e-04 | 31 | 65 | 3 | MM1343 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 4.31e-04 | 138 | 65 | 5 | M29805 | |
| Pathway | WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR | 4.33e-04 | 7 | 65 | 2 | M39689 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_EGF_JAK_STAT_SIGNALING_PATHWAY | 4.33e-04 | 7 | 65 | 2 | M47431 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 4.62e-04 | 33 | 65 | 3 | M6220 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4 | 4.62e-04 | 33 | 65 | 3 | M39455 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 4.64e-04 | 302 | 65 | 7 | M39719 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | 4.85e-04 | 505 | 65 | 9 | MM15548 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 5.50e-04 | 82 | 65 | 4 | MM15394 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER | 5.76e-04 | 83 | 65 | 4 | M27163 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 6.02e-04 | 84 | 65 | 4 | MM14929 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 6.50e-04 | 151 | 65 | 5 | M550 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 6.58e-04 | 86 | 65 | 4 | MM15413 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 7.03e-04 | 38 | 65 | 3 | M27757 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 7.31e-04 | 326 | 65 | 7 | MM15917 | |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | 7.59e-04 | 39 | 65 | 3 | MM14850 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 8.80e-04 | 41 | 65 | 3 | M29574 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 8.84e-04 | 439 | 65 | 8 | M42563 | |
| Pathway | REACTOME_HCMV_INFECTION | 8.93e-04 | 162 | 65 | 5 | M29804 | |
| Pathway | WP_PI3KAKT_SIGNALING | 9.19e-04 | 339 | 65 | 7 | M39736 | |
| Pathway | PID_TCPTP_PATHWAY | 9.45e-04 | 42 | 65 | 3 | M91 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 1.05e-03 | 252 | 65 | 6 | MM15585 | |
| Pathway | REACTOME_SUMOYLATION | 1.08e-03 | 169 | 65 | 5 | MM14919 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 1.08e-03 | 44 | 65 | 3 | MM14520 | |
| Pathway | BIOCARTA_CBL_PATHWAY | 1.12e-03 | 11 | 65 | 2 | MM1360 | |
| Pathway | BIOCARTA_PRC2_PATHWAY | 1.12e-03 | 11 | 65 | 2 | MM1548 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.12e-03 | 11 | 65 | 2 | M47958 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 1.12e-03 | 11 | 65 | 2 | MM14760 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.23e-03 | 46 | 65 | 3 | M239 | |
| Pathway | WP_ERBB_SIGNALING_PATHWAY | 1.23e-03 | 46 | 65 | 3 | MM15950 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.34e-03 | 12 | 65 | 2 | M47393 | |
| Pathway | BIOCARTA_CBL_PATHWAY | 1.34e-03 | 12 | 65 | 2 | M16973 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.36e-03 | 178 | 65 | 5 | M2890 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 1.46e-03 | 367 | 65 | 7 | M48346 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 1.57e-03 | 50 | 65 | 3 | M553 | |
| Pathway | REACTOME_PI3K_AKT_SIGNALING_IN_CANCER | 1.65e-03 | 110 | 65 | 4 | M27162 | |
| Pathway | REACTOME_CELL_CYCLE | 1.70e-03 | 603 | 65 | 9 | MM14635 | |
| Pathway | REACTOME_TRNA_PROCESSING | 1.70e-03 | 111 | 65 | 4 | M27684 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.71e-03 | 277 | 65 | 6 | MM15414 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 1.82e-03 | 113 | 65 | 4 | MM14783 | |
| Pathway | BIOCARTA_PRC2_PATHWAY | 1.84e-03 | 14 | 65 | 2 | M22025 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.86e-03 | 53 | 65 | 3 | M27212 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 2.13e-03 | 118 | 65 | 4 | M713 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 2.34e-03 | 121 | 65 | 4 | M39823 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 2.41e-03 | 16 | 65 | 2 | M47381 | |
| Pathway | REACTOME_POLO_LIKE_KINASE_MEDIATED_EVENTS | 2.41e-03 | 16 | 65 | 2 | M26971 | |
| Pathway | WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2 | 2.41e-03 | 16 | 65 | 2 | M39484 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS | 2.41e-03 | 16 | 65 | 2 | M29847 | |
| Pathway | REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS | 2.53e-03 | 59 | 65 | 3 | M27606 | |
| Pathway | PID_SYNDECAN_3_PATHWAY | 2.72e-03 | 17 | 65 | 2 | M251 | |
| Pathway | BIOCARTA_ARAP_PATHWAY | 2.72e-03 | 17 | 65 | 2 | M2482 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.97e-03 | 532 | 65 | 8 | M27870 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 3.05e-03 | 18 | 65 | 2 | MM1549 | |
| Pubmed | FLNA SFPQ COPA WDR11 RBBP4 RBBP7 MARS1 GART UGDH CAPZB HSD17B4 PLK1 EIF2AK2 HSPA5 ALPK2 NUP153 DDX1 ATP5F1B PHB1 | 1.85e-13 | 809 | 89 | 19 | 32129710 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | FLNA SFPQ RBBP4 MARS1 PURA GART SRBD1 EIF2AK2 HSPA5 DDX1 HERC5 ATP5F1B PHB1 | 1.70e-12 | 316 | 89 | 13 | 31665637 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FLNA SFPQ RPS6KA4 COPA EGFR WDR11 RBBP4 MARS1 DNAJC11 GART CAPZB CORO1B SRBD1 CTTN EIF2AK2 HSPA5 NUP153 DDX1 DNMT1 ATP5F1B PHB1 | 5.56e-12 | 1257 | 89 | 21 | 36526897 |
| Pubmed | CACNA1C FLNA SFPQ RGPD8 COPA SACS DNAJC11 RGPD3 EML6 DDX42 VPS13A CAPZB FUNDC2 SRBD1 HSD17B4 CTTN HSPA5 DDX1 FER1L6 ATP5F1B PHB1 RGPD5 | 9.30e-12 | 1442 | 89 | 22 | 35575683 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NUP50 FLNA SFPQ ALDH1A2 RAPGEF6 RBBP7 MARS1 GART STEEP1 DDX42 KIF4A NBN CORO1B CTTN NUP153 HERC5 DNMT1 ATP5F1B | 2.27e-11 | 934 | 89 | 18 | 33916271 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NUP50 FLNA SFPQ COPA RBBP4 MARS1 VPS13C DNAJC11 GART DDX42 CAPZB HSD17B4 CTTN CCDC86 EIF2AK2 HSPA5 NUP153 DDX1 DNMT1 ATP5F1B PHB1 | 5.71e-11 | 1425 | 89 | 21 | 30948266 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | FLNA SFPQ COPA RBBP7 MARS1 DDX42 KIF4A CORO1B SRBD1 PLK1 CCDC86 EIF2AK2 HSPA5 NUP153 DDX1 DNMT1 ATP5F1B PHB1 | 5.76e-11 | 989 | 89 | 18 | 36424410 |
| Pubmed | SFPQ COPA RBBP4 RBBP7 MARS1 UGDH CAPZB CTTN DNMT1 ATP5F1B PHB1 | 6.91e-11 | 259 | 89 | 11 | 31162944 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNA SFPQ COPA SACS RBBP4 MARS1 PRKAA1 GART DDX42 CAPZB HSD17B4 CTTN CCDC86 HSPA5 NUP153 DDX1 ATP5F1B PHB1 | 1.01e-10 | 1024 | 89 | 18 | 24711643 |
| Pubmed | FLNA RAPGEF6 RBBP4 RBBP7 STEEP1 CAPZB KIF4A NBN CORO1B CTTN PLK1 HSPA5 DNMT1 RGPD5 | 1.31e-10 | 549 | 89 | 14 | 38280479 | |
| Pubmed | FLNA PNKP SFPQ COPA EGFR RBBP4 RBBP7 GART DDX42 CAPZB KIF4A CTTN CCDC86 EIF2AK2 DDX1 | 1.33e-10 | 660 | 89 | 15 | 32780723 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | NUP50 FLNA SFPQ RGPD3 GART STEEP1 CAPZB KIF4A PLK1 HSPA5 NUP153 ATP5F1B | 1.33e-10 | 357 | 89 | 12 | 37059091 |
| Pubmed | FLNA SFPQ RBBP7 PURA GART DDX42 CAPZB SRBD1 CTTN EIF2AK2 HSPA5 DDX1 ATP5F1B PHB1 | 1.37e-10 | 551 | 89 | 14 | 34728620 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNA SFPQ COPA WDR11 RBBP4 MARS1 GART UGDH CAPZB KIF4A CORO1B SRBD1 PLK1 CCDC86 EIF2AK2 HSPA5 DDX1 DNMT1 ATP5F1B PHB1 | 1.68e-10 | 1353 | 89 | 20 | 29467282 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SFPQ COPA RBBP4 RBBP7 PURA DDX42 KIF4A NBN CTTN PLK1 STK24 HSPA5 NUP153 DDX1 | 2.79e-10 | 582 | 89 | 14 | 20467437 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NUP50 FLNA SFPQ RBBP4 RBBP7 STEEP1 DDX42 KIF4A NBN CTTN CCDC86 HSPA5 NUP153 DDX1 DNMT1 ATP5F1B PHB1 | 2.91e-10 | 954 | 89 | 17 | 36373674 |
| Pubmed | FLNA PNKP SFPQ SELENBP1 COPA RBBP4 MARS1 STK26 DNAJC11 GART UGDH CAPZB KIF4A CORO1B CTTN EIF2AK2 HSPA5 DDX1 ATP5F1B | 3.14e-10 | 1247 | 89 | 19 | 27684187 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | NUP50 PNKP NSUN6 SFPQ ALDH1A2 RBBP4 RBBP7 STK26 PURA GART CCDC86 EIF2AK2 STK24 HSPA5 ATP5F1B | 3.24e-10 | 704 | 89 | 15 | 32994395 |
| Pubmed | FLNA ERBB2 SFPQ COPA RBBP7 PURA PRKAA1 GART CCDC86 EIF2AK2 DDX1 HERC5 DNMT1 ATP5F1B | 4.24e-10 | 601 | 89 | 14 | 33658012 | |
| Pubmed | NUP50 FLNA SFPQ RBBP7 STEEP1 CAPZB KIF4A CORO1B CTTN NUP153 DDX1 ATP5F1B PHB1 | 5.77e-10 | 506 | 89 | 13 | 30890647 | |
| Pubmed | NUP50 SFPQ WDR11 RBBP4 RBBP7 MARS1 GART STEEP1 CAPZB NBN HSD17B4 CTTN PLK1 CCDC86 EIF2AK2 HSPA5 DDX1 ATP5F1B PHB1 | 9.75e-10 | 1335 | 89 | 19 | 29229926 | |
| Pubmed | O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma. | NUP50 SFPQ RBBP4 RGPD3 DDX42 CAPZB CCDC86 EIF2AK2 NUP153 ATP5F1B | 1.11e-09 | 254 | 89 | 10 | 36604567 |
| Pubmed | FLNA SFPQ COPA RBBP7 GART KIF4A EIF2AK2 HSPA5 NUP153 DNMT1 ATP5F1B PHB1 | 1.46e-09 | 441 | 89 | 12 | 31239290 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | SFPQ RGPD8 COPA RBBP4 RBBP7 MARS1 RGPD3 GART DDX42 CAPZB CTTN DDX1 DNMT1 PHB1 | 1.56e-09 | 665 | 89 | 14 | 30457570 |
| Pubmed | 2.00e-09 | 83 | 89 | 7 | 11114734 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | FLNA SFPQ COPA EGFR RBBP7 MARS1 PRKAA1 GART CAPZB KIF4A HSD17B4 CTTN CCDC86 EIF2AK2 HSPA5 DDX1 DNMT1 ATP5F1B PHB1 | 2.53e-09 | 1415 | 89 | 19 | 28515276 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | SFPQ RGPD8 COPA WDR11 RBBP4 RBBP7 MARS1 STK26 DNAJC11 RGPD3 GART HSD17B4 PLK1 HSPA5 DDX1 ATP5F1B PHB1 RGPD5 | 2.62e-09 | 1257 | 89 | 18 | 37317656 |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | FLNA SFPQ COPA EGFR RBBP4 GART CAPZB CTTN STK24 HSPA5 DDX1 ATP5F1B PHB1 | 2.99e-09 | 580 | 89 | 13 | 35676659 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | FLNA SFPQ RBBP4 RBBP7 MARS1 PURA DDX42 CAPZB HSD17B4 CTTN HSPA5 DDX1 ATP5F1B PHB1 | 3.85e-09 | 714 | 89 | 14 | 28302793 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NUP50 PNKP SFPQ COPA RBBP4 RBBP7 RGPD3 STEEP1 DDX42 KIF4A NBN SRBD1 CCDC86 HSPA5 NUP153 DNMT1 ATP5F1B PHB1 | 4.12e-09 | 1294 | 89 | 18 | 30804502 |
| Pubmed | 4.62e-09 | 215 | 89 | 9 | 35973513 | ||
| Pubmed | FLNA SFPQ COPA WDR11 RBBP4 MARS1 ALDH1L2 DNAJC11 GART EIF2AK2 HSPA5 DDX1 ATP5F1B PHB1 | 4.67e-09 | 725 | 89 | 14 | 27025967 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FLNA SFPQ COPA RBBP4 RBBP7 MARS1 STK26 GART DDX42 CAPZB CORO1B CTTN EIF2AK2 HSPA5 NUP153 DDX1 ATP5F1B | 4.77e-09 | 1149 | 89 | 17 | 35446349 |
| Pubmed | COL4A2 COPA EGFR RBBP4 MARS1 DNAJC11 GART CAPZB PLK1 HSPA5 CEMIP2 ATP5F1B PHB1 | 5.77e-09 | 613 | 89 | 13 | 22268729 | |
| Pubmed | NUP50 PNKP SFPQ COPA RBBP4 RBBP7 STEEP1 DDX42 KIF4A NBN CTTN EIF2AK2 NUP153 DDX1 DNMT1 PHB1 | 5.84e-09 | 1014 | 89 | 16 | 32416067 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | FLNA SFPQ RGPD8 RBBP4 RBBP7 RGPD3 CAPZB KIF4A CORO1B EIF2AK2 HSPA5 DDX1 RGPD5 | 7.40e-09 | 626 | 89 | 13 | 33644029 |
| Pubmed | FLNA SFPQ COPA RBBP4 MARS1 STK26 GART HSD17B4 HSPA5 NUP153 DDX1 ATP5F1B PHB1 | 9.26e-09 | 638 | 89 | 13 | 33239621 | |
| Pubmed | SORT1 NUP50 COPA EGFR WDR11 KCTD3 VPS13A NBN HSD17B4 PLK1 CCDC86 PLK4 HSPA5 NUP153 CEMIP2 DNMT1 | 9.40e-09 | 1049 | 89 | 16 | 27880917 | |
| Pubmed | NUP50 FLNA SFPQ COPA GART UGDH CAPZB NBN HSD17B4 HSPA5 NUP153 PHB1 | 1.23e-08 | 534 | 89 | 12 | 35032548 | |
| Pubmed | 1.35e-08 | 330 | 89 | 10 | 32529326 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 15026342 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 19283847 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 12532415 | ||
| Pubmed | AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer. | 1.62e-08 | 3 | 89 | 3 | 26143491 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 19370475 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 24862237 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 23100016 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 25468910 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | COL4A2 FLNA SFPQ SELENBP1 COPA MARS1 GART CAPZB TDRD10 HSPA5 DDX1 RYR1 ATP5F1B PHB1 | 1.79e-08 | 807 | 89 | 14 | 30575818 |
| Pubmed | 1.79e-08 | 340 | 89 | 10 | 24332808 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | FLNA SFPQ RPS6KA4 COPA RBBP7 MARS1 GART STEEP1 CAPZB CTTN CCDC86 EIF2AK2 HSPA5 DDX1 HERC5 | 1.81e-08 | 949 | 89 | 15 | 36574265 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | NUP50 FLNA SFPQ RBBP4 RBBP7 RGPD3 STEEP1 DDX42 NBN CTTN HSPA5 | 1.94e-08 | 444 | 89 | 11 | 34795231 |
| Pubmed | FLNA RAP1GAP SFPQ SELENBP1 COPA SACS RBBP7 MARS1 STK26 PURA PRKAA1 CAPZB CORO1B CTTN HSPA5 DDX1 TBC1D24 ATP5F1B | 1.94e-08 | 1431 | 89 | 18 | 37142655 | |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | 2.10e-08 | 256 | 89 | 9 | 24189400 | |
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | 2.24e-08 | 258 | 89 | 9 | 21081666 | |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 2.37e-08 | 182 | 89 | 8 | 30711629 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | OARD1 NUP50 FLNA COPA RBBP4 RBBP7 MARS1 STK26 GART UGDH CAPZB IREB2 CORO1B CTTN STK24 HSPA5 DDX1 ATP5F1B | 2.50e-08 | 1455 | 89 | 18 | 22863883 |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | RGPD8 COPA RBBP4 RBBP7 MARS1 PURA RGPD3 STEEP1 DDX42 DDX1 DNMT1 ATP5F1B PHB1 | 2.80e-08 | 701 | 89 | 13 | 30196744 |
| Pubmed | 2.81e-08 | 186 | 89 | 8 | 14744259 | ||
| Pubmed | SFPQ COPA PURA GART UGDH SRBD1 HSD17B4 PLK1 EIF2AK2 HSPA5 DDX1 | 3.39e-08 | 469 | 89 | 11 | 37314180 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 3.42e-08 | 271 | 89 | 9 | 32433965 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | FLNA SFPQ COPA RBBP4 RBBP7 MARS1 DNAJC11 GART HSD17B4 PLK1 EIF2AK2 HSPA5 NUP153 DDX1 DNMT1 ATP5F1B PHB1 | 3.56e-08 | 1318 | 89 | 17 | 30463901 |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | 4.67e-08 | 281 | 89 | 9 | 30455355 | |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | NUP50 FLNA SFPQ COPA RBBP4 RBBP7 GART CAPZB CTTN HSPA5 ATP5F1B | 5.85e-08 | 495 | 89 | 11 | 28581483 |
| Pubmed | Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay. | 6.47e-08 | 4 | 89 | 3 | 24557338 | |
| Pubmed | Inverse regulation of EGFR/HER1 and HER2-4 in normal and malignant human breast tissue. | 6.47e-08 | 4 | 89 | 3 | 23991224 | |
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 22327010 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 17177598 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 36411648 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 21203579 | ||
| Pubmed | ErbB2 and ErbB4 Cbl binding sites can functionally replace the ErbB1 Cbl binding site. | 6.47e-08 | 4 | 89 | 3 | 19263517 | |
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 19447869 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 18985033 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 9556621 | ||
| Pubmed | Expression of the HER-1-4 family of receptor tyrosine kinases in neuroendocrine tumours. | 6.47e-08 | 4 | 89 | 3 | 20204273 | |
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 12807903 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 27069134 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 26021752 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 16685269 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 15345710 | ||
| Pubmed | Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. | 6.47e-08 | 4 | 89 | 3 | 12621152 | |
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 22854050 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 9771475 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 15733067 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 8816440 | ||
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 9.91e-08 | 219 | 89 | 8 | 31353912 | |
| Pubmed | 1.01e-07 | 87 | 89 | 6 | 24169447 | ||
| Pubmed | FLNA SFPQ COPA WDR11 RBBP4 STK26 PURA DDX42 HSPA5 DDX1 DNMT1 PHB1 | 1.10e-07 | 653 | 89 | 12 | 33742100 | |
| Pubmed | FLNA SFPQ COPA RBBP4 RBBP7 GART DDX42 KIF4A CCDC86 NUP153 HERC5 DNMT1 | 1.10e-07 | 653 | 89 | 12 | 22586326 | |
| Pubmed | Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin. | 1.18e-07 | 149 | 89 | 7 | 26370502 | |
| Pubmed | PNKP SFPQ RBBP4 RBBP7 HSD17B4 EIF2AK2 HSPA5 DDX1 DNMT1 ATP5F1B | 1.26e-07 | 419 | 89 | 10 | 15635413 | |
| Pubmed | 1.32e-07 | 421 | 89 | 10 | 34650049 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | FLNA SFPQ COPA EGFR ALDH1L2 LPCAT3 PRKAA1 GART DDX42 UGDH FUNDC2 HSD17B4 CTTN HSPA5 DDX1 ATP5F1B PHB1 | 1.41e-07 | 1451 | 89 | 17 | 30550785 |
| Pubmed | Phosphotyrosine interactome of the ErbB-receptor kinase family. | 1.51e-07 | 19 | 89 | 4 | 16729043 | |
| Pubmed | 1.52e-07 | 323 | 89 | 9 | 24797263 | ||
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 10572067 | ||
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 15682390 | ||
| Pubmed | Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer. | 1.61e-07 | 5 | 89 | 3 | 25416285 | |
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 15254894 | ||
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 23137868 | ||
| Interaction | IFI16 interactions | NUP50 FLNA SFPQ RGPD8 COPA EGFR RBBP4 MARS1 PURA RGPD3 GART SRBD1 CCDC86 EIF2AK2 HSPA5 NUP153 DDX1 HERC5 DNMT1 ATP5F1B PHB1 | 2.75e-12 | 714 | 88 | 21 | int:IFI16 |
| Interaction | EED interactions | COL4A2 FLNA PNKP SFPQ RPS6KA4 SELENBP1 COPA RBBP4 RBBP7 MARS1 VPS13C STK26 PRKAA1 GART DDX42 CAPZB KIF4A CORO1B HSD17B4 CTTN PLK1 HSPA5 DDX1 DNMT1 ATP5F1B PHB1 | 2.68e-10 | 1445 | 88 | 26 | int:EED |
| Interaction | STAP1 interactions | 1.60e-09 | 27 | 88 | 6 | int:STAP1 | |
| Interaction | RICTOR interactions | FLNA RGPD8 COPA EGFR RBBP4 RBBP7 STK26 RGPD3 GART NBN RIPK4 CTTN PLK1 CCDC86 STK24 HSPA5 PHB1 RGPD5 | 3.88e-09 | 759 | 88 | 18 | int:RICTOR |
| Interaction | FGFR1OP2 interactions | 7.83e-09 | 94 | 88 | 8 | int:FGFR1OP2 | |
| Interaction | XRCC6 interactions | NUP50 FLT1 PNKP SFPQ RPS6KA4 EGFR RBBP4 GART STEEP1 DDX42 CAPZB KIF4A NBN HSD17B4 HSPA5 NUP153 DNMT1 ATP5F1B PHB1 | 1.46e-08 | 928 | 88 | 19 | int:XRCC6 |
| Interaction | SNW1 interactions | NUP50 FLNA SFPQ COPA EGFR RBBP7 PURA STEEP1 DDX42 KIF4A NBN CTTN PLK1 HSPA5 NUP153 DDX1 ATP5F1B | 2.05e-08 | 747 | 88 | 17 | int:SNW1 |
| Interaction | PPM1F interactions | 2.52e-08 | 71 | 88 | 7 | int:PPM1F | |
| Interaction | NAA40 interactions | NUP50 FLNA SFPQ ALDH1A2 RAPGEF6 WDR11 RBBP7 MARS1 GART STEEP1 DDX42 KIF4A NBN CORO1B CTTN NUP153 HERC5 DNMT1 ATP5F1B | 3.37e-08 | 978 | 88 | 19 | int:NAA40 |
| Interaction | BTRC interactions | FLNA ERBB2 RAP1GAP SFPQ ALDH1A2 AATK CSF1R EML5 RIPK4 CTTN PLK4 HSPA5 NUP153 DDX1 HERC5 TBC1D24 ATP5F1B | 3.51e-08 | 775 | 88 | 17 | int:BTRC |
| Interaction | SUMO2 interactions | FLNA SELENBP1 COPA EGFR RBBP4 RBBP7 MARS1 KIF4A NBN NPEPL1 EIF2AK2 HSPA5 NUP153 DDX1 DNMT1 | 3.76e-08 | 591 | 88 | 15 | int:SUMO2 |
| Interaction | DNAJC7 interactions | EML5 EGFR SACS VPS13C DNAJC11 GART VPS13A FUNDC2 RIPK4 MTCH1 HSPA5 HERC5 PHB1 | 3.89e-08 | 425 | 88 | 13 | int:DNAJC7 |
| Interaction | BIRC3 interactions | NUP50 FLNA SFPQ COPA EGFR RBBP4 MARS1 DNAJC11 GART DDX42 CAPZB RIPK4 HSD17B4 CTTN CCDC86 EIF2AK2 HSPA5 NUP153 DDX1 DNMT1 ATP5F1B PHB1 | 4.26e-08 | 1334 | 88 | 22 | int:BIRC3 |
| Interaction | CBL interactions | FLNA ERBB2 FLT1 ERBB4 CSF1R EGFR CAPZB KIF4A CTTN PLK1 KIT HSPA5 HERC5 PHB1 | 4.95e-08 | 516 | 88 | 14 | int:CBL |
| Interaction | STIP1 interactions | FLNA ERBB2 SFPQ COPA EGFR RBBP4 MARS1 STK26 PURA GART CAPZB RIPK4 HSD17B4 MTCH1 HSPA5 NUP153 DDX1 ATP5F1B PHB1 | 5.27e-08 | 1006 | 88 | 19 | int:STIP1 |
| Interaction | SH2B3 interactions | 7.02e-08 | 25 | 88 | 5 | int:SH2B3 | |
| Interaction | STYX interactions | 8.19e-08 | 84 | 88 | 7 | int:STYX | |
| Interaction | HDAC6 interactions | NUP50 FLNA ERBB2 ERBB4 SFPQ COPA EGFR RBBP4 GART CAPZB NBN CTTN PLK1 STK24 HSPA5 DDX1 ATP5F1B PHB1 | 8.58e-08 | 929 | 88 | 18 | int:HDAC6 |
| Interaction | DNAJA2 interactions | KLHL11 ERBB2 EML5 EGFR SACS RBBP4 RBBP7 DNAJC11 KCTD3 CAPZB RIPK4 MTCH1 HSPA5 PHB1 | 9.08e-08 | 542 | 88 | 14 | int:DNAJA2 |
| Interaction | TEC interactions | 1.32e-07 | 90 | 88 | 7 | int:TEC | |
| Interaction | SLX4 interactions | NUP50 FLNA SFPQ RGPD3 GART STEEP1 CAPZB KIF4A NBN HSD17B4 PLK1 HSPA5 NUP153 ATP5F1B | 1.75e-07 | 572 | 88 | 14 | int:SLX4 |
| Interaction | CIT interactions | NUP50 FLNA ERBB4 PNKP SFPQ COPA RBBP4 RBBP7 MARS1 RGPD3 GART DDX42 CAPZB CORO1B SRBD1 CCDC86 EIF2AK2 HSPA5 NUP153 DDX1 ATP5F1B PHB1 | 1.84e-07 | 1450 | 88 | 22 | int:CIT |
| Interaction | YAP1 interactions | FLNA ERBB4 SFPQ RAPGEF6 COPA EGFR RBBP4 RBBP7 MARS1 STEEP1 CAPZB KIF4A CORO1B CTTN HSPA5 DDX1 DNMT1 ATP5F1B PHB1 | 1.98e-07 | 1095 | 88 | 19 | int:YAP1 |
| Interaction | SPOP interactions | NUP50 SFPQ RBBP4 RGPD3 DDX42 CAPZB HSD17B4 CCDC86 EIF2AK2 HSPA5 NUP153 DDX1 ATP5F1B | 2.07e-07 | 491 | 88 | 13 | int:SPOP |
| Interaction | FBXW7 interactions | FLNA ERBB2 SFPQ COPA EGFR RBBP4 RBBP7 MARS1 PURA PRKAA1 GART DDX42 SRBD1 PLK1 CCDC86 EIF2AK2 DDX1 HERC5 DNMT1 ATP5F1B | 2.07e-07 | 1215 | 88 | 20 | int:FBXW7 |
| Interaction | NUPR1 interactions | FLNA PNKP SFPQ COPA EGFR RBBP4 RBBP7 GART DDX42 CAPZB KIF4A CTTN CCDC86 EIF2AK2 DDX1 | 2.45e-07 | 683 | 88 | 15 | int:NUPR1 |
| Interaction | ACTC1 interactions | NUP50 FLNA TNNI3K SFPQ AATK RBBP7 STEEP1 CAPZB KIF4A CORO1B CTTN NUP153 DDX1 ATP5F1B PHB1 | 3.01e-07 | 694 | 88 | 15 | int:ACTC1 |
| Interaction | DDRGK1 interactions | SFPQ COPA WDR11 RBBP4 RBBP7 MARS1 STK26 PURA CAPZB SRBD1 HSD17B4 CCDC86 EIF2AK2 MTCH1 HSPA5 DDX1 HERC5 DNMT1 ATP5F1B PHB1 | 3.22e-07 | 1249 | 88 | 20 | int:DDRGK1 |
| Interaction | PTPN20 interactions | 3.29e-07 | 14 | 88 | 4 | int:PTPN20 | |
| Interaction | RACK1 interactions | FOCAD ERBB2 FLT1 EGFR RBBP4 RBBP7 MARS1 PRKAA1 CAPZB RIPK4 HSD17B4 PLK1 HERC5 PPTC7 PHB1 | 3.61e-07 | 704 | 88 | 15 | int:RACK1 |
| Interaction | HDAC5 interactions | FLNA SFPQ RBBP4 RBBP7 MARS1 PRKAA1 KCTD3 HSD17B4 HSPA5 DDX1 ATP5F1B PHB1 | 3.81e-07 | 432 | 88 | 12 | int:HDAC5 |
| Interaction | KIF23 interactions | FLNA SFPQ COPA EGFR WDR11 MARS1 STK26 PURA GART CAPZB LAMA2 HSD17B4 PLK1 STK24 HSPA5 DDX1 HERC5 ATP5F1B | 4.01e-07 | 1031 | 88 | 18 | int:KIF23 |
| Interaction | HNRNPU interactions | FOCAD NUP50 PNKP SFPQ EGFR GART CAPZB SRBD1 HSD17B4 PLK1 CCDC86 MTCH1 STK24 HSPA5 NUP153 DDX1 HERC5 PHB1 | 4.25e-07 | 1035 | 88 | 18 | int:HNRNPU |
| Interaction | SNCA interactions | FLNA PNKP SFPQ COPA EGFR SACS VPS13C DDX42 UGDH HSD17B4 CTTN PLK1 EIF2AK2 HSPA5 HERC5 | 4.47e-07 | 716 | 88 | 15 | int:SNCA |
| Interaction | MECP2 interactions | NUP50 SFPQ COPA SACS RBBP4 PURA KCTD3 DDX42 CAPZB SRBD1 HSD17B4 CTTN PLK1 CCDC86 EIF2AK2 MTCH1 HSPA5 DDX1 DNMT1 PHB1 | 5.18e-07 | 1287 | 88 | 20 | int:MECP2 |
| Interaction | CTTN interactions | FOCAD FLNA SFPQ EGFR STK26 GART DDX42 UGDH CAPZB CORO1B CTTN HSPA5 | 5.88e-07 | 450 | 88 | 12 | int:CTTN |
| Interaction | MIR140 interactions | 6.65e-07 | 71 | 88 | 6 | int:MIR140 | |
| Interaction | RASA1 interactions | 6.88e-07 | 167 | 88 | 8 | int:RASA1 | |
| Interaction | BAP1 interactions | FLNA SFPQ COPA EGFR RBBP4 RBBP7 MARS1 ALDH1L2 STK26 GART DDX42 CAPZB NBN CORO1B CTTN EIF2AK2 HSPA5 NUP153 DDX1 ATP5F1B | 7.18e-07 | 1314 | 88 | 20 | int:BAP1 |
| Interaction | CUL4A interactions | ERBB2 ERBB4 COPA EGFR WDR11 RBBP4 RBBP7 MARS1 PURA UGDH PLK1 HSPA5 DDX1 HERC5 DNMT1 ATP5F1B | 7.79e-07 | 854 | 88 | 16 | int:CUL4A |
| Interaction | UBE2M interactions | NUP50 FLNA SFPQ COPA EGFR RBBP4 RBBP7 GART KCTD3 CAPZB CTTN HSPA5 HERC5 ATP5F1B | 8.30e-07 | 651 | 88 | 14 | int:UBE2M |
| Interaction | RGPD8 interactions | 8.52e-07 | 74 | 88 | 6 | int:RGPD8 | |
| Interaction | TNPO1 interactions | 8.92e-07 | 306 | 88 | 10 | int:TNPO1 | |
| Interaction | CCDC8 interactions | FLNA SFPQ COPA SACS RBBP4 RBBP7 MARS1 PRKAA1 GART CAPZB HSD17B4 HSPA5 ATP5F1B PHB1 | 9.09e-07 | 656 | 88 | 14 | int:CCDC8 |
| Interaction | NPIPB6 interactions | 9.91e-07 | 18 | 88 | 4 | int:NPIPB6 | |
| Interaction | FBXW11 interactions | NUP50 FLNA RAP1GAP AATK CSF1R EML5 EGFR WDR11 RIPK4 PLK4 NUP153 ATP5F1B | 9.93e-07 | 473 | 88 | 12 | int:FBXW11 |
| Interaction | RAN interactions | NUP50 RGPD8 EGFR RBBP4 RBBP7 MARS1 RGPD3 HSPA5 NUP153 HERC5 PHB1 RGPD5 | 1.04e-06 | 475 | 88 | 12 | int:RAN |
| Interaction | HSPA4 interactions | FOCAD ERBB2 EGFR RBBP4 RBBP7 PRKAA1 GART CAPZB NBN RIPK4 PLK1 HSPA5 DNMT1 PHB1 | 1.11e-06 | 667 | 88 | 14 | int:HSPA4 |
| Interaction | SH3KBP1 interactions | 1.16e-06 | 315 | 88 | 10 | int:SH3KBP1 | |
| Interaction | HUWE1 interactions | KLHL11 SFPQ COPA EGFR RBBP4 RBBP7 MARS1 PURA CAPZB RIPK4 HSPA5 NUP153 DDX1 HERC5 TBC1D24 ATP5F1B PHB1 RGPD5 | 1.17e-06 | 1110 | 88 | 18 | int:HUWE1 |
| Interaction | MATK interactions | 1.20e-06 | 43 | 88 | 5 | int:MATK | |
| Interaction | SMC5 interactions | NUP50 FLNA SFPQ RBBP4 RBBP7 STEEP1 DDX42 KIF4A NBN CTTN CCDC86 HSPA5 NUP153 DDX1 DNMT1 ATP5F1B PHB1 | 1.28e-06 | 1000 | 88 | 17 | int:SMC5 |
| Interaction | SHC2 interactions | 1.34e-06 | 44 | 88 | 5 | int:SHC2 | |
| Interaction | ADARB1 interactions | FLNA SFPQ PURA STEEP1 KIF4A NBN CORO1B CCDC86 EIF2AK2 HSPA5 NUP153 DDX1 | 1.40e-06 | 489 | 88 | 12 | int:ADARB1 |
| Interaction | ACTR2 interactions | 1.45e-06 | 323 | 88 | 10 | int:ACTR2 | |
| Interaction | PIN4 interactions | 1.46e-06 | 81 | 88 | 6 | int:PIN4 | |
| Interaction | OBSL1 interactions | FLNA SFPQ COPA RBBP4 GART DDX42 CAPZB CTTN CCDC86 EIF2AK2 HSPA5 ALPK2 NUP153 DDX1 ATP5F1B PHB1 | 1.59e-06 | 902 | 88 | 16 | int:OBSL1 |
| Interaction | UFL1 interactions | FLNA SFPQ COPA EGFR RBBP4 RBBP7 DNAJC11 GART CAPZB SRBD1 EIF2AK2 MTCH1 HSPA5 DDX1 HERC5 ATP5F1B PHB1 | 1.94e-06 | 1031 | 88 | 17 | int:UFL1 |
| Interaction | STK26 interactions | 1.97e-06 | 192 | 88 | 8 | int:STK26 | |
| Interaction | PLCG1 interactions | 2.30e-06 | 264 | 88 | 9 | int:PLCG1 | |
| Interaction | PRMT1 interactions | FLNA SFPQ EGFR RBBP7 PURA GART DDX42 CAPZB NBN SRBD1 CTTN EIF2AK2 HSPA5 DDX1 ATP5F1B PHB1 | 2.34e-06 | 929 | 88 | 16 | int:PRMT1 |
| Interaction | RGPD4 interactions | 2.34e-06 | 22 | 88 | 4 | int:RGPD4 | |
| Interaction | SHC4 interactions | 2.34e-06 | 22 | 88 | 4 | int:SHC4 | |
| Interaction | BAG5 interactions | COPA EGFR RBBP7 VPS13C DNAJC11 GART UGDH CAPZB RIPK4 ATP5F1B | 2.36e-06 | 341 | 88 | 10 | int:BAG5 |
| Interaction | CALM3 interactions | 2.49e-06 | 343 | 88 | 10 | int:CALM3 | |
| Interaction | NUP93 interactions | 2.68e-06 | 269 | 88 | 9 | int:NUP93 | |
| Interaction | FBP1 interactions | 2.83e-06 | 348 | 88 | 10 | int:FBP1 | |
| Interaction | G3BP1 interactions | FLNA COPA EGFR RBBP4 MARS1 PURA RGPD3 PRKAA1 CAPZB CORO1B HSD17B4 EIF2AK2 HSPA5 DDX1 PHB1 | 3.03e-06 | 835 | 88 | 15 | int:G3BP1 |
| Interaction | CUL4B interactions | FLNA SFPQ EGFR RBBP4 RBBP7 MARS1 CAPZB NBN HSD17B4 HSPA5 NUP153 DDX1 HERC5 DNMT1 | 3.08e-06 | 728 | 88 | 14 | int:CUL4B |
| Interaction | OGT interactions | NUP50 PNKP NSUN6 SFPQ ALDH1A2 EGFR RBBP4 RBBP7 STK26 PURA GART CCDC86 EIF2AK2 STK24 HSPA5 ATP5F1B | 3.11e-06 | 950 | 88 | 16 | int:OGT |
| Interaction | C9orf72 interactions | SFPQ RGPD8 COPA WDR11 RBBP4 RBBP7 MARS1 STK26 DNAJC11 RGPD3 GART HSD17B4 PLK1 MTCH1 HSPA5 DDX1 ATP5F1B PHB1 RGPD5 | 3.25e-06 | 1319 | 88 | 19 | int:C9orf72 |
| Interaction | EIF2S1 interactions | 3.31e-06 | 276 | 88 | 9 | int:EIF2S1 | |
| Interaction | SOCS5 interactions | 3.37e-06 | 24 | 88 | 4 | int:SOCS5 | |
| Interaction | SLA2 interactions | 3.37e-06 | 24 | 88 | 4 | int:SLA2 | |
| Interaction | CUL7 interactions | FLNA SFPQ COPA RBBP4 MARS1 GART DDX42 CAPZB HSD17B4 PLK1 HSPA5 DDX1 HERC5 ATP5F1B PHB1 | 3.50e-06 | 845 | 88 | 15 | int:CUL7 |
| Interaction | MCM2 interactions | FLNA SFPQ RGPD8 EGFR RBBP4 MARS1 RGPD3 PRKAA1 GART CAPZB PLK1 EIF2AK2 HSPA5 DDX1 ATP5F1B PHB1 RGPD5 | 3.68e-06 | 1081 | 88 | 17 | int:MCM2 |
| Interaction | USP11 interactions | SORT1 COPA EGFR RBBP4 RBBP7 CAPZB PLK1 HSPA5 NUP153 DDX1 ATP5F1B PHB1 | 3.84e-06 | 539 | 88 | 12 | int:USP11 |
| Interaction | HSH2D interactions | 4.00e-06 | 25 | 88 | 4 | int:HSH2D | |
| Interaction | CDC5L interactions | SFPQ COPA EGFR RBBP4 RBBP7 STEEP1 DDX42 CAPZB KIF4A NBN PLK1 EIF2AK2 STK24 HSPA5 PHB1 | 4.04e-06 | 855 | 88 | 15 | int:CDC5L |
| Interaction | EIF5A interactions | 4.05e-06 | 283 | 88 | 9 | int:EIF5A | |
| Interaction | TXNIP interactions | 4.11e-06 | 212 | 88 | 8 | int:TXNIP | |
| Interaction | VAV3 interactions | 4.15e-06 | 55 | 88 | 5 | int:VAV3 | |
| Interaction | CDC37 interactions | TNNI3K ERBB2 AATK RPS6KA4 CSF1R EGFR STK26 PRKAA1 CAPZB RIPK4 CTTN EIF2AK2 HSPA5 | 4.34e-06 | 645 | 88 | 13 | int:CDC37 |
| Interaction | NDN interactions | FLNA SFPQ EGFR RBBP4 GART CAPZB CORO1B CTTN HSPA5 DDX1 ATP5F1B | 4.43e-06 | 453 | 88 | 11 | int:NDN |
| Interaction | TXK interactions | 4.96e-06 | 57 | 88 | 5 | int:TXK | |
| Interaction | PLCG2 interactions | 5.00e-06 | 100 | 88 | 6 | int:PLCG2 | |
| Interaction | EEF1A1 interactions | FLNA SFPQ EGFR GART VPS13A CAPZB IREB2 CTTN HSPA5 DDX1 FER1L6 DNMT1 ATP5F1B PHB1 | 5.21e-06 | 762 | 88 | 14 | int:EEF1A1 |
| Interaction | FLII interactions | 6.16e-06 | 298 | 88 | 9 | int:FLII | |
| Interaction | KARS1 interactions | 6.61e-06 | 383 | 88 | 10 | int:KARS1 | |
| Interaction | MUC4 interactions | 6.63e-06 | 9 | 88 | 3 | int:MUC4 | |
| Interaction | HSP90AA1 interactions | FLNA TNNI3K ERBB2 ERBB4 AATK RPS6KA4 CSF1R EGFR RBBP4 RBBP7 PRKAA1 CAPZB NBN RIPK4 EIF2AK2 HSPA5 ATP5F1B PHB1 | 7.18e-06 | 1263 | 88 | 18 | int:HSP90AA1 |
| Interaction | PPM1A interactions | 7.29e-06 | 163 | 88 | 7 | int:PPM1A | |
| Interaction | EP300 interactions | FLNA SFPQ COPA EGFR WDR11 RBBP4 RBBP7 MARS1 STK26 PURA PRKAA1 GART DDX42 NBN CTTN HSPA5 DDX1 DNMT1 PHB1 | 7.77e-06 | 1401 | 88 | 19 | int:EP300 |
| Interaction | ANAPC2 interactions | 8.47e-06 | 234 | 88 | 8 | int:ANAPC2 | |
| Interaction | MEN1 interactions | SFPQ RBBP4 RBBP7 MARS1 PURA DDX42 UGDH NBN SRBD1 HSD17B4 PLK1 CCDC86 EIF2AK2 NUP153 DDX1 ATP5F1B | 8.57e-06 | 1029 | 88 | 16 | int:MEN1 |
| Interaction | SOCS3 interactions | 8.68e-06 | 110 | 88 | 6 | int:SOCS3 | |
| Interaction | ARPC5 interactions | 8.68e-06 | 110 | 88 | 6 | int:ARPC5 | |
| Interaction | RECQL4 interactions | NUP50 SFPQ WDR11 RBBP4 RBBP7 MARS1 GART STEEP1 CAPZB NBN HSD17B4 CTTN PLK1 CCDC86 EIF2AK2 HSPA5 DDX1 ATP5F1B PHB1 | 8.69e-06 | 1412 | 88 | 19 | int:RECQL4 |
| Interaction | BTF3 interactions | FLNA SFPQ RGPD8 EGFR RBBP4 RBBP7 RGPD3 CAPZB KIF4A CORO1B EIF2AK2 HSPA5 DDX1 RGPD5 | 8.93e-06 | 799 | 88 | 14 | int:BTF3 |
| Interaction | ATG16L1 interactions | PIKFYVE FLNA COPA EGFR RBBP4 RBBP7 MARS1 VPS13C PURA STEEP1 DDX42 STK24 DDX1 DNMT1 ATP5F1B PHB1 RGPD5 | 9.48e-06 | 1161 | 88 | 17 | int:ATG16L1 |
| Cytoband | 2q13 | 3.22e-04 | 68 | 89 | 3 | 2q13 | |
| Cytoband | 13q12 | 9.98e-04 | 24 | 89 | 2 | 13q12 | |
| GeneFamily | Erb-b2 receptor tyrosine kinases | 1.25e-07 | 4 | 58 | 3 | 1096 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 7.99e-06 | 40 | 58 | 4 | 321 | |
| GeneFamily | WD repeat domain containing | 1.98e-05 | 262 | 58 | 7 | 362 | |
| GeneFamily | Lysine methyltransferases|Myb/SANT domain containing|Polycomb repressive complex 2 | 1.50e-04 | 6 | 58 | 2 | 1347 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.84e-04 | 181 | 58 | 5 | 694 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 3.59e-04 | 9 | 58 | 2 | 1306 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 6.54e-04 | 12 | 58 | 2 | 1243 | |
| GeneFamily | PHD finger proteins|NuRD complex | 6.54e-04 | 12 | 58 | 2 | 1305 | |
| GeneFamily | Aldehyde dehydrogenases | 1.67e-03 | 19 | 58 | 2 | 398 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 1.85e-03 | 20 | 58 | 2 | 1371 | |
| GeneFamily | Nucleoporins | 4.72e-03 | 32 | 58 | 2 | 1051 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 6.00e-03 | 115 | 58 | 3 | 769 | |
| GeneFamily | DEAD-box helicases | 8.02e-03 | 42 | 58 | 2 | 499 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 1.08e-02 | 49 | 58 | 2 | 584 | |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_DN | 2.49e-07 | 341 | 89 | 10 | M2879 | |
| Coexpression | GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 5.50e-06 | 200 | 89 | 7 | M299 | |
| Coexpression | GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_UP | 5.50e-06 | 200 | 89 | 7 | M9699 | |
| Coexpression | HALLMARK_E2F_TARGETS | 5.50e-06 | 200 | 89 | 7 | M5925 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP | 5.50e-06 | 200 | 89 | 7 | M5777 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | FOCAD PNKP SFPQ GART DDX42 KIF4A PLK1 NUP153 DDX1 DNMT1 PHB1 | 7.22e-06 | 612 | 89 | 11 | M4772 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | NUP50 FLNA COPA WDR11 RBBP4 RBBP7 LPCAT3 GART KCTD3 CAPZB NBN HSD17B4 STK24 NUP153 DDX1 ATP5F1B | 1.75e-05 | 1399 | 89 | 16 | M535 |
| Coexpression | HAY_BONE_MARROW_ERYTHROBLAST | SELENBP1 RBBP4 LPCAT3 DNAJC11 GART FUNDC2 KIF4A HSD17B4 PLK1 CCDC86 PLK4 DDX1 DNMT1 ATP5F1B PHB1 | 2.31e-05 | 1271 | 89 | 15 | M39197 |
| Coexpression | FISCHER_DREAM_TARGETS | OARD1 NUP50 SFPQ RAPGEF6 RBBP4 MARS1 PRKAA1 GART KIF4A PLK1 PLK4 NUP153 DNMT1 | 2.32e-05 | 969 | 89 | 13 | M149 |
| Coexpression | ACEVEDO_LIVER_CANCER_UP | OARD1 SORT1 FOCAD COL4A2 SELENBP1 COPA WDR11 RBBP7 MARS1 PURA KCTD3 NUP153 DNMT1 | 2.40e-05 | 972 | 89 | 13 | M15709 |
| Coexpression | PUJANA_BREAST_CANCER_LIT_INT_NETWORK | 2.47e-05 | 101 | 89 | 5 | M15356 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | NUP50 RAP1GAP SFPQ MRO RBBP4 PRKAA1 GART KCTD3 KIF4A NBN PLK1 CCDC86 PLK4 NUP153 DNMT1 | 2.74e-05 | 1290 | 89 | 15 | M80 |
| Coexpression | VEGF_A_UP.V1_DN | 5.16e-05 | 193 | 89 | 6 | M2675 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 6.11e-05 | 199 | 89 | 6 | M5893 | |
| Coexpression | GSE22886_NEUTROPHIL_VS_MONOCYTE_DN | 6.11e-05 | 199 | 89 | 6 | M4467 | |
| Coexpression | GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_UP | 6.29e-05 | 200 | 89 | 6 | M4663 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 6.29e-05 | 200 | 89 | 6 | M5901 | |
| Coexpression | GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN | 6.29e-05 | 200 | 89 | 6 | M3613 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_4H_BMDC_UP | 6.29e-05 | 200 | 89 | 6 | M3803 | |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_UP | 6.75e-05 | 64 | 89 | 4 | M3958 | |
| Coexpression | PEART_HDAC_PROLIFERATION_CLUSTER_DN | 1.01e-04 | 71 | 89 | 4 | M1421 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 1.05e-04 | 681 | 89 | 10 | M39175 | |
| Coexpression | BIDUS_METASTASIS_UP | 1.09e-04 | 221 | 89 | 6 | M15866 | |
| Coexpression | HWANG_PROSTATE_CANCER_MARKERS | 1.17e-04 | 28 | 89 | 3 | M6195 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 1.37e-04 | 569 | 89 | 9 | M12701 | |
| Coexpression | STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP | 1.44e-04 | 30 | 89 | 3 | M19548 | |
| Coexpression | WONG_EMBRYONIC_STEM_CELL_CORE | 1.47e-04 | 335 | 89 | 7 | M7079 | |
| Coexpression | GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_DN | 1.78e-04 | 153 | 89 | 5 | M8815 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | 2.34e-04 | 481 | 89 | 8 | M3898 | |
| Coexpression | GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP | 2.89e-04 | 170 | 89 | 5 | M5657 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 2.91e-04 | 630 | 89 | 9 | MM1038 | |
| Coexpression | TCGA_GLIOBLASTOMA_MUTATED | 3.15e-04 | 8 | 89 | 2 | M19387 | |
| Coexpression | KANG_CISPLATIN_RESISTANCE_DN | 3.15e-04 | 8 | 89 | 2 | M8236 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 3.67e-04 | 179 | 89 | 5 | M39308 | |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | 4.48e-04 | 187 | 89 | 5 | M6807 | |
| Coexpression | LI_ESTROGENE_MID_E2_RESPONSE_DN | 4.84e-04 | 45 | 89 | 3 | M48216 | |
| Coexpression | MOHANKUMAR_HOXA1_TARGETS_UP | 4.99e-04 | 410 | 89 | 7 | M4399 | |
| Coexpression | BASAKI_YBX1_TARGETS_UP | 5.04e-04 | 294 | 89 | 6 | M14985 | |
| Coexpression | NUTT_GBM_VS_AO_GLIOMA_UP | 5.17e-04 | 46 | 89 | 3 | M6921 | |
| Coexpression | MARCHINI_TRABECTEDIN_RESISTANCE_DN | 5.17e-04 | 46 | 89 | 3 | M8349 | |
| Coexpression | GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP | 5.17e-04 | 193 | 89 | 5 | M3303 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | SFPQ RGPD8 COPA DNAJC11 RGPD3 PRKAA1 RGP1 MTCH1 STK24 NUP153 DDX1 PPTC7 | 5.37e-04 | 1158 | 89 | 12 | MM1338 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_UP | 5.64e-04 | 111 | 89 | 4 | M40928 | |
| Coexpression | GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP | 5.68e-04 | 197 | 89 | 5 | M3144 | |
| Coexpression | GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN | 5.68e-04 | 197 | 89 | 5 | M8871 | |
| Coexpression | GSE12366_GC_VS_MEMORY_BCELL_UP | 5.81e-04 | 198 | 89 | 5 | M3171 | |
| Coexpression | GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN | 5.94e-04 | 199 | 89 | 5 | M8979 | |
| Coexpression | GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN | 5.94e-04 | 199 | 89 | 5 | M7099 | |
| Coexpression | GSE3982_CTRL_VS_LPS_4H_MAC_DN | 5.94e-04 | 199 | 89 | 5 | M5368 | |
| Coexpression | GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_DN | 5.94e-04 | 199 | 89 | 5 | M3594 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_UP | 5.94e-04 | 199 | 89 | 5 | M8266 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_UP | 5.94e-04 | 199 | 89 | 5 | M3439 | |
| Coexpression | GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP | 5.94e-04 | 199 | 89 | 5 | M8477 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN | 5.94e-04 | 199 | 89 | 5 | M3912 | |
| Coexpression | GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_DN | 5.94e-04 | 199 | 89 | 5 | M7390 | |
| Coexpression | GSE5960_TH1_VS_ANERGIC_TH1_UP | 5.94e-04 | 199 | 89 | 5 | M5637 | |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP | 6.08e-04 | 200 | 89 | 5 | M4601 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_UP | 6.08e-04 | 200 | 89 | 5 | M9336 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_UP | 6.08e-04 | 200 | 89 | 5 | M4570 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP | 6.08e-04 | 200 | 89 | 5 | M7905 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN | 6.08e-04 | 200 | 89 | 5 | M6617 | |
| Coexpression | GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_DN | 6.08e-04 | 200 | 89 | 5 | M8218 | |
| Coexpression | GSE27786_LIN_NEG_VS_CD8_TCELL_UP | 6.08e-04 | 200 | 89 | 5 | M4775 | |
| Coexpression | GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_DN | 6.08e-04 | 200 | 89 | 5 | M3607 | |
| Coexpression | GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN | 6.08e-04 | 200 | 89 | 5 | M3604 | |
| Coexpression | GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_UP | 6.08e-04 | 200 | 89 | 5 | M4115 | |
| Coexpression | GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_UP | 6.08e-04 | 200 | 89 | 5 | M5476 | |
| Coexpression | GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_DN | 6.08e-04 | 200 | 89 | 5 | M8531 | |
| Coexpression | GSE7852_THYMUS_VS_FAT_TCONV_UP | 6.08e-04 | 200 | 89 | 5 | M5749 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_UP | 6.08e-04 | 200 | 89 | 5 | M3860 | |
| Coexpression | GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_DN | 6.08e-04 | 200 | 89 | 5 | M5619 | |
| Coexpression | JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP | 6.23e-04 | 49 | 89 | 3 | M2202 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-07 | 192 | 89 | 7 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | droplet-Limb_Muscle-nan-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-06 | 180 | 89 | 6 | d3d0be136fff5d3e39ecf5a5dbefc1d0d0a6c814 | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|normal_Lung / Location, Cell class and cell subclass | 1.72e-06 | 181 | 89 | 6 | b55dbcfae8c92d322071906831489830a22239b9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-06 | 192 | 89 | 6 | 8769b67d1cad1be65da3938f916e5bf88f88f6b8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-06 | 192 | 89 | 6 | 7af2b5240b1fad2177d8022e5f4fc1fe9e8f03b5 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-06 | 192 | 89 | 6 | 32e4a180037e516c5cc798cd9dada9385e0f43ae | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.81e-06 | 197 | 89 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.89e-06 | 198 | 89 | 6 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | Immune_cells-large_pre-B.|Immune_cells / Lineage and Cell class | 2.89e-06 | 198 | 89 | 6 | bc9ceefadb153907d2854d1f736d17349003cb31 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.89e-06 | 198 | 89 | 6 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 89 | 6 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 89 | 6 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.06e-06 | 200 | 89 | 6 | 694ebc8cc14f80b6f2f4acec4ce7452d8b816af8 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 89 | 6 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 89 | 6 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.06e-06 | 200 | 89 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 89 | 6 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 89 | 6 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.20e-05 | 168 | 89 | 5 | 4b5be7c6662eceddf90a65015f12908278d1664e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.20e-05 | 168 | 89 | 5 | 689c41f6e9f65381570991cc311cba49a57ec955 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 169 | 89 | 5 | ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 169 | 89 | 5 | c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.54e-05 | 173 | 89 | 5 | ef8d720b99470fe1953661f6e66bc0366266bdb6 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.83e-05 | 177 | 89 | 5 | 0e74980a7686c31fcf1476b8f19a3392541df240 | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.99e-05 | 179 | 89 | 5 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.15e-05 | 181 | 89 | 5 | 73b1b59810f60e3e39ca1d5073a5a0d4f5377e6e | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-05 | 181 | 89 | 5 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-05 | 181 | 89 | 5 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-05 | 188 | 89 | 5 | 0a874578f5692a896ea3071a17d87cdeb242fb11 | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.87e-05 | 189 | 89 | 5 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-05 | 189 | 89 | 5 | 6e52cac679e0541ca5f2be316bdabdbc34da6e18 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 3.97e-05 | 190 | 89 | 5 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-05 | 190 | 89 | 5 | 888ded899f0513d41bf655896d59ae8ef74e0978 | |
| ToppCell | facs-Skin-Anagen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-05 | 190 | 89 | 5 | 3466cebab16964e94da130d0673fa32e7d90b5ed | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 192 | 89 | 5 | 2d9e2262f1342fe17735f21f733c029d1275e955 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.27e-05 | 193 | 89 | 5 | ad2df9b77999780860141be6ec366afc0172a331 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-05 | 193 | 89 | 5 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-05 | 194 | 89 | 5 | 4d7fc4d0a55abb3b645116d13a983bbedc55f70c | |
| ToppCell | facs-Skin-Telogen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-05 | 194 | 89 | 5 | ba10fc5929649bb994c3f1d2ce6ca3167fa9b11b | |
| ToppCell | facs-Skin-Telogen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-05 | 194 | 89 | 5 | bafecab8d48fc94ffd93f0d054b5f32c04b6b3f6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.49e-05 | 195 | 89 | 5 | 83c125223e7ca0f08a31414b3a16347912564765 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.49e-05 | 195 | 89 | 5 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 4.60e-05 | 196 | 89 | 5 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-05 | 196 | 89 | 5 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | Control-Myeloid-TRAM3|Control / Disease group,lineage and cell class （2021.01.30） | 4.71e-05 | 197 | 89 | 5 | 733ff40039d67e561c2ded7c9bd0b4353101741e | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.71e-05 | 197 | 89 | 5 | 8e655db7c6f04d49927a1f0a75178e5955b4af08 | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.71e-05 | 197 | 89 | 5 | 4416efdbd9c4ac3356a5dff2d535c2d7383376a9 | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.71e-05 | 197 | 89 | 5 | 0f1c4a328968b32874e6ebb0803e665adcbbc450 | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.71e-05 | 197 | 89 | 5 | aafe0cd697b0b7f0756596148e0906443fdf8ef7 | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.71e-05 | 197 | 89 | 5 | e131634bc67e0bd31a938a8e8df8dc752e1d0f47 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 4.83e-05 | 198 | 89 | 5 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.83e-05 | 198 | 89 | 5 | 08982f9e37591261975ddff9b9a6a59ba836fc0f | |
| ToppCell | Severe-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.83e-05 | 198 | 89 | 5 | 8402421dc060926e968efe39a4e907f1e8ae5b1f | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.83e-05 | 198 | 89 | 5 | 45a1287dc618a37949978b297e2b782ea80a7f39 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_1|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.83e-05 | 198 | 89 | 5 | f801157468e59b5d049f703feadc9bb0f11e85cc | |
| ToppCell | severe-Lymphocytic-Prol._cells|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.94e-05 | 199 | 89 | 5 | b24315952b6ac6c8d2d3a7bd949a5b5392624d4e | |
| ToppCell | Severe-Developping_Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.06e-05 | 200 | 89 | 5 | 6d0cd00e52568d23597cc2a4059bd967d7d2dab5 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.06e-05 | 200 | 89 | 5 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 5.06e-05 | 200 | 89 | 5 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Activated_fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.06e-05 | 200 | 89 | 5 | 2518d1758e2730b028270e76b949cebbeb7fb5ce | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.06e-05 | 200 | 89 | 5 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.51e-04 | 153 | 89 | 4 | 9c6fce56300ba5053efda59a438d63a808c497c0 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.63e-04 | 155 | 89 | 4 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.77e-04 | 157 | 89 | 4 | 2c946c6ab284fac3c25db688ed0aabe5a3f9ffa5 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.90e-04 | 159 | 89 | 4 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.19e-04 | 163 | 89 | 4 | bbbc3f0ce2616d07136f69ce682ba1d3790711d9 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.19e-04 | 163 | 89 | 4 | d6f9b7280c44d120df5a72dfc2ebb26ffbb5752b | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.26e-04 | 164 | 89 | 4 | ad508f53009efdd1dae7abcdb5431387f3f7e7b2 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.26e-04 | 164 | 89 | 4 | 11dfd84f5fb90de330858e1e852848832734e004 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.58e-04 | 168 | 89 | 4 | d60f7cd8269f373827f49c7785002cb38e4570a9 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-04 | 168 | 89 | 4 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.58e-04 | 168 | 89 | 4 | f3879a8e11eaf866f37c52e67021be43f0b8784a | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-04 | 168 | 89 | 4 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-04 | 169 | 89 | 4 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-04 | 169 | 89 | 4 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.66e-04 | 169 | 89 | 4 | ccd98f9005aa0a88bd49f153be4e7200cc3dd0ac | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 3.74e-04 | 170 | 89 | 4 | 9e328e1f904c77dcce8aee4df775d7f0ac725775 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 171 | 89 | 4 | 8e7223ba447947cdf4e1c82a52fd90439cf3d8f6 | |
| ToppCell | facs-Trachea-nan-24m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 171 | 89 | 4 | d2a10e94b0490120d1420b944302eb841f902c64 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 172 | 89 | 4 | ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.91e-04 | 172 | 89 | 4 | eee45759284baa3ed77da6a5fbcc4f8f6c553106 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 172 | 89 | 4 | bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.00e-04 | 173 | 89 | 4 | 5295ed31648abf8edff214cf67cd4769f20f9e6d | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_2|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.08e-04 | 174 | 89 | 4 | a75ba49ccea6bd3d78ada1092b46deb5202c58a5 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.08e-04 | 174 | 89 | 4 | 110369f6b78de34a6d934b5b47cecd023347bc80 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.08e-04 | 174 | 89 | 4 | 4da79da7a09ee1e345102c5331675ebcdbe56171 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.17e-04 | 175 | 89 | 4 | 3b5346fba617292de71963b6175e85a4f182fe30 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.17e-04 | 175 | 89 | 4 | 9142ed8ca2f1c0c518deb21988221406f62fe38c | |
| ToppCell | Influenza_Severe-Plasmablast|World / Disease group and Cell class | 4.17e-04 | 175 | 89 | 4 | 14df8fc6f6beae1be7b7bd5837546d1ac1239a6f | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.26e-04 | 176 | 89 | 4 | 269326c2bf44a9003d95bc6dbc839f08f25737ca | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.26e-04 | 176 | 89 | 4 | dc4e939a07bad21ab36181f9588df3fa662f9a92 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.26e-04 | 176 | 89 | 4 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.36e-04 | 177 | 89 | 4 | 84116796ca4c7007508c0f1a68a1135c7b922278 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-04 | 177 | 89 | 4 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.36e-04 | 177 | 89 | 4 | 1cb78133ac09ea3a3f5b5de07151033998406512 | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast-Mast_cell_lympho|lymph-node_spleen / Manually curated celltypes from each tissue | 4.36e-04 | 177 | 89 | 4 | 53040dbeb18574a48e352e4bce252c7c3018762c | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.36e-04 | 177 | 89 | 4 | d2c1f46913ac00bbc0bb9320d5652edc01b34179 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.36e-04 | 177 | 89 | 4 | 65e090aad0ffb737ce034e25bd5b12a0b1dd9684 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 178 | 89 | 4 | 15a99080e9f669572ab6d82934f324e6714846c1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.45e-04 | 178 | 89 | 4 | 2a36475c260088f69f3b8c282d910e5eaa5c5c2d | |
| Drug | 4-anilinoquinazoline | 3.25e-09 | 16 | 88 | 5 | CID000324081 | |
| Drug | sunitinib | 3.98e-08 | 130 | 88 | 8 | CID005329102 | |
| Drug | pyrido[3,4-d]pyrimidine | 5.58e-08 | 3 | 88 | 3 | CID014758064 | |
| Drug | Pb-D | 8.37e-08 | 143 | 88 | 8 | CID000070065 | |
| Drug | vandetanib | 1.13e-07 | 99 | 88 | 7 | CID003081361 | |
| Drug | quinazoline | 3.28e-07 | 71 | 88 | 6 | CID000009210 | |
| Drug | deazapurine | 1.93e-06 | 7 | 88 | 3 | CID000261591 | |
| Drug | Sunitinib | 3.08e-06 | 8 | 88 | 3 | DB01268 | |
| Drug | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 3.63e-06 | 315 | 88 | 9 | ctd:D015632 | |
| Drug | K00271 | 4.61e-06 | 9 | 88 | 3 | CID005486761 | |
| Drug | 6-(methylamino)pyrido(3,4-d)pyrimidine | 6.57e-06 | 10 | 88 | 3 | ctd:C107875 | |
| Drug | ponatinib | 6.62e-06 | 68 | 88 | 5 | ctd:C545373 | |
| Drug | NVP & EFV | 7.55e-06 | 121 | 88 | 6 | CID000492400 | |
| Drug | BE-23372M | 9.00e-06 | 11 | 88 | 3 | CID005311105 | |
| Drug | beta-tyrosine | 9.95e-06 | 35 | 88 | 4 | CID000440311 | |
| Drug | GW843682X | 1.48e-05 | 2 | 88 | 2 | CID009826308 | |
| Drug | N-(2-(4-((3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)amino)-5H-pyrrolo(3,2-d)pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide | 1.48e-05 | 2 | 88 | 2 | ctd:C570404 | |
| Drug | Lapatinib | 1.48e-05 | 2 | 88 | 2 | DB01259 | |
| Drug | TX-1123 | 1.48e-05 | 2 | 88 | 2 | CID000403661 | |
| Drug | oxindole-pyridine, 5 | 1.48e-05 | 2 | 88 | 2 | CID011751896 | |
| Drug | thieno[2,3-c]pyridine, 9a | 1.48e-05 | 2 | 88 | 2 | CID010216158 | |
| Drug | AC1L45LU | 1.48e-05 | 205 | 88 | 7 | CID000151069 | |
| Drug | Dasatinib | 1.58e-05 | 478 | 88 | 10 | ctd:D000069439 | |
| Drug | gedunin | 1.87e-05 | 84 | 88 | 5 | ctd:C106014 | |
| Drug | dimethyl phthalate | SORT1 ERBB2 FLT1 SFPQ ALDH1A2 LPCAT3 PURA KIF4A NBN HSD17B4 EIF2AK2 PLK4 | 1.91e-05 | 714 | 88 | 12 | ctd:C024629 |
| Drug | Curcumin | COL4A2 ERBB2 FLT1 SFPQ CSF1R EGFR PRKAA1 PLK1 KIT PLK4 HSPA5 DNMT1 PHB1 | 2.25e-05 | 850 | 88 | 13 | ctd:D003474 |
| Drug | CEP-701 | 2.29e-05 | 43 | 88 | 4 | CID000126565 | |
| Drug | axitinib | 2.75e-05 | 45 | 88 | 4 | CID006450551 | |
| Drug | PKI166 | 3.56e-05 | 48 | 88 | 4 | CID006918403 | |
| Drug | imatinib | 4.30e-05 | 430 | 88 | 9 | CID000005291 | |
| Drug | 5-iodonicotinic acid | 4.42e-05 | 3 | 88 | 2 | CID000151950 | |
| Drug | 2-acetamidoethanethiol | 4.42e-05 | 3 | 88 | 2 | ctd:C023704 | |
| Drug | 4557 W | 4.42e-05 | 3 | 88 | 2 | ctd:C433938 | |
| Drug | 4-aminopyrimidine-5-carbaldehyde | 4.42e-05 | 3 | 88 | 2 | CID011228787 | |
| Drug | AC1L1JYL | 4.62e-05 | 434 | 88 | 9 | CID000005262 | |
| Drug | I-BOP | 5.28e-05 | 53 | 88 | 4 | CID005311175 | |
| Drug | CI-1033 | 5.28e-05 | 53 | 88 | 4 | CID000156413 | |
| Drug | lavendustin A | 5.35e-05 | 171 | 88 | 6 | CID000003894 | |
| Drug | 4-hydroxy-2-nonenal | ERBB2 ERBB4 CSF1R SELENBP1 CAPZB NBN CTTN PLK1 EIF2AK2 HSPA5 HERC5 PHB1 | 5.64e-05 | 798 | 88 | 12 | ctd:C027576 |
| Drug | Prestwick_517 | 5.73e-05 | 106 | 88 | 5 | CID000003804 | |
| Drug | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | SORT1 ERBB2 SELENBP1 EGFR KIF4A PLK1 EIF2AK2 HSPA5 DNMT1 ATP5F1B | 5.86e-05 | 558 | 88 | 10 | ctd:C072553 |
| Drug | tanespimycin | 6.56e-05 | 56 | 88 | 4 | ctd:C112765 | |
| Drug | PTK/ZK | 6.56e-05 | 56 | 88 | 4 | CID000151193 | |
| Drug | sunitinib | 7.04e-05 | 57 | 88 | 4 | ctd:C473478 | |
| Drug | AC1NS44W | 8.61e-05 | 60 | 88 | 4 | CID005353385 | |
| Drug | AC1L3VO5 | 8.80e-05 | 116 | 88 | 5 | CID000123015 | |
| Drug | PD168393 | 8.82e-05 | 4 | 88 | 2 | CID000004708 | |
| Drug | tyrphostin AG825 | 8.82e-05 | 4 | 88 | 2 | CID000002062 | |
| Drug | DODCI | 8.82e-05 | 4 | 88 | 2 | CID000003147 | |
| Drug | EGFR/ErbB2 inhibitor | 8.82e-05 | 4 | 88 | 2 | CID009843206 | |
| Drug | (4-(4'-chloro-2'-fluoro)phenylamino)-6,7-dimethylquinazoline | 8.82e-05 | 4 | 88 | 2 | ctd:C575425 | |
| Drug | prenyl bromide | 8.82e-05 | 4 | 88 | 2 | CID000070092 | |
| Drug | 3-bromoaniline | 8.82e-05 | 4 | 88 | 2 | CID000011562 | |
| Drug | genistein | PIKFYVE GPLD1 CACNA1C ERBB2 FLT1 ERBB4 RPS6KA4 EGFR LAMA2 KIT PLK4 HSPA5 RYR1 DNMT1 | 9.29e-05 | 1117 | 88 | 14 | CID005280961 |
| Drug | AC1L1CT9 | 9.34e-05 | 23 | 88 | 3 | CID000002054 | |
| Drug | alkannin beta-hydroxyisovalerate | 9.34e-05 | 23 | 88 | 3 | CID000100203 | |
| Drug | Go6976 | 9.59e-05 | 190 | 88 | 6 | CID000003501 | |
| Drug | Methotrexate [59-05-2]; Up 200; 8.8uM; HL60; HG-U133A | 9.87e-05 | 191 | 88 | 6 | 2041_UP | |
| Drug | Paclitaxel | COL4A2 ERBB2 FLT1 ERBB4 EGFR LAMA2 HSD17B4 CTTN PLK1 KIT PLK4 | 1.03e-04 | 720 | 88 | 11 | ctd:D017239 |
| Drug | fulvestrant | 1.06e-04 | 484 | 88 | 9 | ctd:C070081 | |
| Drug | Lysergol [602-85-7]; Up 200; 15.8uM; PC3; HT_HG-U133A | 1.07e-04 | 194 | 88 | 6 | 6621_UP | |
| Drug | sunitinib malate | 1.11e-04 | 64 | 88 | 4 | CID006456015 | |
| Drug | AC1NE222 | 1.18e-04 | 65 | 88 | 4 | CID004635324 | |
| Drug | Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 1.20e-04 | 198 | 88 | 6 | 6246_DN | |
| Drug | Mercuric Chloride | KLHL11 NUP50 FLNA ALDH1A2 COPA EGFR PRKAA1 DDX42 UGDH EIF2AK2 PLK4 HSPA5 DNMT1 PHB1 | 1.32e-04 | 1155 | 88 | 14 | ctd:D008627 |
| Drug | BIBX1382BS | 1.36e-04 | 26 | 88 | 3 | CID006918508 | |
| Drug | RG 14921 | 1.47e-04 | 5 | 88 | 2 | CID000197517 | |
| Drug | 6-quinolinecarbaldehyde | 1.47e-04 | 5 | 88 | 2 | CID000765653 | |
| Drug | TAK-165 | 1.47e-04 | 5 | 88 | 2 | CID006444692 | |
| Drug | Fenofibrate | SORT1 ALDH1A2 CSF1R EGFR LPCAT3 PRKAA1 NBN HSD17B4 HSPA5 ALPK2 | 1.47e-04 | 624 | 88 | 10 | ctd:D011345 |
| Drug | benzylidenemalononitrile | 1.53e-04 | 27 | 88 | 3 | CID000017608 | |
| Drug | saracatinib | 1.53e-04 | 27 | 88 | 3 | CID010302451 | |
| Drug | everolimus | 1.86e-04 | 136 | 88 | 5 | CID006442177 | |
| Drug | ketopantoate | 1.90e-04 | 29 | 88 | 3 | CID000000038 | |
| Drug | Anilino | 1.90e-04 | 29 | 88 | 3 | CID000137550 | |
| Drug | flavopiridol | 1.93e-04 | 216 | 88 | 6 | CID005287969 | |
| Drug | Isoflavones | 2.03e-04 | 218 | 88 | 6 | ctd:D007529 | |
| Drug | tripterine | 2.06e-04 | 139 | 88 | 5 | ctd:C050414 | |
| Drug | NSC292228 | 2.10e-04 | 30 | 88 | 3 | CID000001010 | |
| Drug | 1 x OE | 2.10e-04 | 30 | 88 | 3 | CID000449200 | |
| Drug | NSC226080 | PIKFYVE ERBB2 FLT1 ERBB4 RAPGEF6 RPS6KA4 CSF1R SELENBP1 EGFR KIT RYR1 | 2.11e-04 | 782 | 88 | 11 | CID000005040 |
| Drug | Fluorouracil | COL4A2 ERBB2 FLT1 ERBB4 EGFR RBBP4 MARS1 PURA GART UGDH IREB2 NBN CTTN PLK1 KIT | 2.16e-04 | 1364 | 88 | 15 | ctd:D005472 |
| Drug | SCH 49210 | 2.19e-04 | 6 | 88 | 2 | CID000158548 | |
| Drug | B-31 | 2.19e-04 | 6 | 88 | 2 | CID000122475 | |
| Drug | Cochliobolic acid | 2.19e-04 | 6 | 88 | 2 | CID006450172 | |
| Drug | SnCe6 | 2.19e-04 | 6 | 88 | 2 | CID000164259 | |
| Drug | triethyl orthoformate | 2.19e-04 | 6 | 88 | 2 | CID000031214 | |
| Drug | ZD-6 | 2.19e-04 | 6 | 88 | 2 | CID010062753 | |
| Drug | pendolmycin | 2.19e-04 | 6 | 88 | 2 | CID000154206 | |
| Drug | 2alpha-propoxy-1alpha,25-dihydroxyvitamin D3 | 2.19e-04 | 6 | 88 | 2 | CID010062706 | |
| Drug | diethyl ester | 2.19e-04 | 6 | 88 | 2 | CID000264327 | |
| Drug | AC1L1O6Q | 2.20e-04 | 141 | 88 | 5 | CID000058035 | |
| Drug | delphinidin | 2.55e-04 | 32 | 88 | 3 | ctd:C017185 | |
| Drug | Anthraquinones | 2.55e-04 | 32 | 88 | 3 | ctd:D000880 | |
| Drug | sorafenib | 2.84e-04 | 149 | 88 | 5 | ctd:C471405 | |
| Drug | SNS-032 | 3.06e-04 | 34 | 88 | 3 | CID003025986 | |
| Drug | imetelstat | 3.06e-04 | 7 | 88 | 2 | ctd:C519562 | |
| Drug | RG 14467 | 3.06e-04 | 7 | 88 | 2 | CID000132069 | |
| Drug | PKI 166 | 3.06e-04 | 7 | 88 | 2 | ctd:C410026 | |
| Drug | secoisolariciresinol diglucoside | 3.06e-04 | 7 | 88 | 2 | ctd:C090142 | |
| Disease | carcinoma (implicated_via_orthology) | 3.60e-08 | 64 | 87 | 6 | DOID:305 (implicated_via_orthology) | |
| Disease | urinary bladder cancer (is_marker_for) | 7.85e-07 | 107 | 87 | 6 | DOID:11054 (is_marker_for) | |
| Disease | renal cell carcinoma (is_marker_for) | 2.24e-06 | 128 | 87 | 6 | DOID:4450 (is_marker_for) | |
| Disease | Squamous cell carcinoma of lung | 2.38e-06 | 32 | 87 | 4 | C0149782 | |
| Disease | Malignant neoplasm of breast | FLNA ERBB2 FLT1 ERBB4 NSUN6 RAP1GAP CSF1R EGFR PRKAA1 LAMA2 NBN KIT DNMT1 PHB1 | 2.99e-06 | 1074 | 87 | 14 | C0006142 |
| Disease | gallbladder neoplasm | 4.02e-06 | 11 | 87 | 3 | C0016978 | |
| Disease | Malignant neoplasm of gallbladder | 4.02e-06 | 11 | 87 | 3 | C0153452 | |
| Disease | Breast Carcinoma | 4.25e-06 | 538 | 87 | 10 | C0678222 | |
| Disease | Neoplasm Recurrence, Local | 5.36e-06 | 39 | 87 | 4 | C0027643 | |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 8.59e-06 | 2 | 87 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 8.59e-06 | 2 | 87 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | median neuropathy (biomarker_via_orthology) | 8.80e-06 | 14 | 87 | 3 | DOID:571 (biomarker_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 9.82e-06 | 96 | 87 | 5 | C1319315 | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 2.32e-05 | 19 | 87 | 3 | DOID:2876 (is_marker_for) | |
| Disease | Carcinoma, Granular Cell | 2.46e-05 | 116 | 87 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 2.46e-05 | 116 | 87 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 2.46e-05 | 116 | 87 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 2.46e-05 | 116 | 87 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 2.46e-05 | 116 | 87 | 5 | C0205641 | |
| Disease | Adenocarcinoma | 2.46e-05 | 116 | 87 | 5 | C0001418 | |
| Disease | Mammary Carcinoma, Human | 2.50e-05 | 525 | 87 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.50e-05 | 525 | 87 | 9 | C1257931 | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 2.57e-05 | 3 | 87 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 2.57e-05 | 3 | 87 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | Mammary Neoplasms | 2.58e-05 | 527 | 87 | 9 | C1458155 | |
| Disease | Adenocarcinoma of lung (disorder) | 3.40e-05 | 206 | 87 | 6 | C0152013 | |
| Disease | transitional cell carcinoma (is_marker_for) | 3.68e-05 | 63 | 87 | 4 | DOID:2671 (is_marker_for) | |
| Disease | bronchiolo-alveolar adenocarcinoma (is_marker_for) | 5.14e-05 | 4 | 87 | 2 | DOID:4926 (is_marker_for) | |
| Disease | Schizophrenia | CACNA1C ERBB4 ALDH1A2 RAPGEF6 EML5 SELENBP1 WDR11 LAMA2 CCDC86 DNMT1 PHB1 | 5.71e-05 | 883 | 87 | 11 | C0036341 |
| Disease | prostate carcinoma in situ (is_marker_for) | 7.69e-05 | 28 | 87 | 3 | DOID:8634 (is_marker_for) | |
| Disease | Cetuximab response | 8.54e-05 | 5 | 87 | 2 | cv:CN077967 | |
| Disease | Panitumumab response | 8.54e-05 | 5 | 87 | 2 | cv:CN077999 | |
| Disease | intestinal cancer (implicated_via_orthology) | 1.15e-04 | 32 | 87 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | melanoma (is_marker_for) | 1.27e-04 | 33 | 87 | 3 | DOID:1909 (is_marker_for) | |
| Disease | leiomyosarcoma (is_marker_for) | 1.28e-04 | 6 | 87 | 2 | DOID:1967 (is_marker_for) | |
| Disease | Glioma | 1.30e-04 | 87 | 87 | 4 | C0017638 | |
| Disease | Disease Exacerbation | 1.31e-04 | 165 | 87 | 5 | C0235874 | |
| Disease | nephroblastoma (is_marker_for) | 1.39e-04 | 34 | 87 | 3 | DOID:2154 (is_marker_for) | |
| Disease | ductal carcinoma in situ (is_marker_for) | 2.10e-04 | 39 | 87 | 3 | DOID:0060074 (is_marker_for) | |
| Disease | Hereditary Diffuse Gastric Cancer | 2.34e-04 | 293 | 87 | 6 | C1708349 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 2.38e-04 | 8 | 87 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | head and neck squamous cell carcinoma (is_marker_for) | 2.38e-04 | 8 | 87 | 2 | DOID:5520 (is_marker_for) | |
| Disease | Stomach Neoplasms | 2.52e-04 | 297 | 87 | 6 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 2.66e-04 | 300 | 87 | 6 | C0024623 | |
| Disease | SPINOCEREBELLAR ATAXIA 17 | 3.05e-04 | 9 | 87 | 2 | C1846707 | |
| Disease | Head and Neck Carcinoma | 3.81e-04 | 10 | 87 | 2 | C3887461 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 4.14e-04 | 49 | 87 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | Alzheimer disease, family history of Alzheimer’s disease | 4.32e-04 | 119 | 87 | 4 | EFO_0009268, MONDO_0004975 | |
| Disease | Medulloblastoma | 4.39e-04 | 50 | 87 | 3 | C0025149 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 4.65e-04 | 11 | 87 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | gastrointestinal stromal tumor (is_implicated_in) | 4.65e-04 | 11 | 87 | 2 | DOID:9253 (is_implicated_in) | |
| Disease | Neoplasm Metastasis | 4.65e-04 | 217 | 87 | 5 | C0027627 | |
| Disease | Small cell carcinoma of lung | 5.51e-04 | 54 | 87 | 3 | C0149925 | |
| Disease | Hematologic Neoplasms | 5.56e-04 | 12 | 87 | 2 | C0376545 | |
| Disease | Papilloma | 5.56e-04 | 12 | 87 | 2 | C0030354 | |
| Disease | Papillomatosis | 5.56e-04 | 12 | 87 | 2 | C0205875 | |
| Disease | Papilloma, Squamous Cell | 5.56e-04 | 12 | 87 | 2 | C0205874 | |
| Disease | Congenital muscular dystrophy | 5.56e-04 | 12 | 87 | 2 | cv:C0699743 | |
| Disease | Malignant Neoplasms | 5.69e-04 | 128 | 87 | 4 | C0006826 | |
| Disease | Malignant neoplasm of skin | 7.14e-04 | 59 | 87 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 7.14e-04 | 59 | 87 | 3 | C0037286 | |
| Disease | Liver carcinoma | 7.59e-04 | 507 | 87 | 7 | C2239176 | |
| Disease | Neoplasm of lung | 7.64e-04 | 14 | 87 | 2 | cv:C0024121 | |
| Disease | Lung cancer | 7.64e-04 | 14 | 87 | 2 | cv:C0242379 | |
| Disease | LUNG CANCER | 7.64e-04 | 14 | 87 | 2 | 211980 | |
| Disease | Animal Mammary Neoplasms | 8.40e-04 | 142 | 87 | 4 | C0024667 | |
| Disease | Mammary Carcinoma, Animal | 8.40e-04 | 142 | 87 | 4 | C1257925 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 8.65e-04 | 63 | 87 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | Spondyloepiphyseal Dysplasia | 1.00e-03 | 16 | 87 | 2 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 1.00e-03 | 16 | 87 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 1.00e-03 | 16 | 87 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 1.00e-03 | 16 | 87 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 1.00e-03 | 16 | 87 | 2 | C0025237 | |
| Disease | reticulocyte measurement | PIKFYVE KLHL11 FLNA RAP1GAP PRKAA1 EML6 VPS13A EIF2AK2 DNMT1 ATP5F1B | 1.07e-03 | 1053 | 87 | 10 | EFO_0010700 |
| Disease | renal cell carcinoma (is_implicated_in) | 1.13e-03 | 69 | 87 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | Dementia | 1.14e-03 | 17 | 87 | 2 | C0497327 | |
| Disease | Van Buchem disease | 1.14e-03 | 17 | 87 | 2 | C0432272 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 1.14e-03 | 17 | 87 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 1.14e-03 | 17 | 87 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 1.14e-03 | 17 | 87 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 1.14e-03 | 17 | 87 | 2 | C0751780 | |
| Disease | May-White Syndrome | 1.14e-03 | 17 | 87 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 1.14e-03 | 17 | 87 | 2 | C0751781 | |
| Disease | Mammary Neoplasms, Experimental | 1.16e-03 | 155 | 87 | 4 | C0024668 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.22e-03 | 71 | 87 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 1.28e-03 | 18 | 87 | 2 | C0751779 | |
| Disease | Carcinomatosis | 1.40e-03 | 163 | 87 | 4 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 1.40e-03 | 163 | 87 | 4 | C0205697 | |
| Disease | Undifferentiated carcinoma | 1.40e-03 | 163 | 87 | 4 | C0205698 | |
| Disease | Anaplastic carcinoma | 1.40e-03 | 163 | 87 | 4 | C0205696 | |
| Disease | Osteochondrodysplasias | 1.42e-03 | 19 | 87 | 2 | C0029422 | |
| Disease | Dyschondroplasias | 1.42e-03 | 19 | 87 | 2 | C0013366 | |
| Disease | Carcinoma | 1.43e-03 | 164 | 87 | 4 | C0007097 | |
| Disease | mean corpuscular hemoglobin concentration | FOCAD NUP50 ALDH1A2 EGFR PRKAA1 VPS13A IREB2 CORO1B PLK4 PHB1 | 1.53e-03 | 1105 | 87 | 10 | EFO_0004528 |
| Disease | myelodysplastic syndrome (is_marker_for) | 1.58e-03 | 20 | 87 | 2 | DOID:0050908 (is_marker_for) | |
| Disease | Multiple Epiphyseal Dysplasia | 1.58e-03 | 20 | 87 | 2 | C0026760 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 1.60e-03 | 169 | 87 | 4 | DOID:3908 (is_marker_for) | |
| Disease | Esophageal Neoplasms | 1.61e-03 | 78 | 87 | 3 | C0014859 | |
| Disease | Malignant neoplasm of esophagus | 1.61e-03 | 78 | 87 | 3 | C0546837 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.73e-03 | 80 | 87 | 3 | DOID:12930 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKNGVVKDVFAFGGA | 1176 | P04626 | |
| VKVLGSGAFGTVYKG | 721 | Q15303 | |
| AGETVTGGFGAKKRK | 201 | Q9H6F5 | |
| ITGFDGGEKALIGFS | 466 | P26358 | |
| VGIATLAKGYKGFKG | 2091 | Q86TB3 | |
| ECGGKGLGRKGFFIE | 386 | O94788 | |
| APFGGVKQSGFGKDL | 891 | Q3SY69 | |
| DGFLFGLKGAKGRAG | 446 | P08572 | |
| GLKGFFGEKGTEGDI | 1116 | P08572 | |
| KFLAVIVEASGGGAF | 46 | Q9BR76 | |
| HGFAGVILIKKAGDG | 126 | P47756 | |
| KIGLFGGAGVGKTVL | 201 | P06576 | |
| ESDTGGAFKGFKGLV | 51 | Q9UKX7 | |
| FESIGKFGLALAVAG | 6 | P35232 | |
| GKKDLNFKGFSGAGE | 986 | Q99666 | |
| GKKDLNFKGFSGAGE | 986 | O14715 | |
| VGVAGKFVEFFGSGV | 346 | P48200 | |
| GAGIAVLFKKKFGGV | 41 | Q9Y530 | |
| RVKGSLKAGFFGTVV | 321 | Q9NVH1 | |
| FGKTLGAGAFGKVVE | 591 | P10721 | |
| DKFGFGFGGTGKKSH | 161 | Q92499 | |
| KRGFGFGGFAISAGK | 11 | Q86XP3 | |
| KTRGFGGIYGVGKAA | 221 | Q8NDH3 | |
| ILTGLGFNGFEEKGK | 296 | Q6P1A2 | |
| FGKREFKAGGEVPAG | 221 | Q96KN4 | |
| GTGFAKAVGGFKVGL | 2946 | P24043 | |
| VVLGKIQGKGLGSFF | 116 | Q9BYG7 | |
| TGAYGKVFLVRKAGG | 41 | O75676 | |
| GAKEFDGTKVFLGNG | 161 | Q8TEA1 | |
| EKGEFGGFGSVSGKI | 101 | Q09028 | |
| KGEFGGFGSVTGKIE | 101 | Q16576 | |
| GEIGYDLGGVKKEFF | 716 | Q9UII4 | |
| LVTAGCGFGKDFRKG | 36 | Q8NI37 | |
| FGKKDLNFKGFSGAG | 986 | A6NKT7 | |
| PGGKKFDSVVVNGFV | 671 | Q9Y2I7 | |
| RGGIFGSDGKDFVDK | 406 | Q96EW2 | |
| KVLGSGAFGTVYKGL | 716 | P00533 | |
| GAFGKVVEATAFGLG | 591 | P07333 | |
| FGLTEVKGKLYSIGG | 446 | Q9NVR0 | |
| ANALGGKGAGFDVKA | 221 | Q13936 | |
| ELIGSGGFGQVFKAK | 271 | P19525 | |
| GKDQEFTVKSKGAGG | 986 | P21333 | |
| GFFEGTIASKGKGGA | 816 | P53621 | |
| VVVNDLGGDFKGVGK | 36 | P51659 | |
| TFGKKFIGVEAGGTL | 216 | Q9UHN6 | |
| GNVISALGDDKKGGF | 271 | O95239 | |
| ALEKGFVTGGKDGIV | 911 | Q05BV3 | |
| ALDKGFVTGGKDGIV | 911 | Q6ZMW3 | |
| GEKNILVFDLGGGTF | 216 | P11021 | |
| KRGEVDKVGKFGLGF | 1546 | Q9NZJ4 | |
| SLFGGGLVEGAKKVT | 4361 | P21817 | |
| IEFRKKGGFEGGGFL | 751 | Q9Y597 | |
| AAIGFFITGGKKGPE | 1366 | Q5VW36 | |
| FQKVGKLAATAVGGG | 101 | Q9BWH2 | |
| GLDGDRVIGKFKGSF | 1311 | Q2WGJ9 | |
| GKIFKEEGLLGFFVG | 241 | Q9NZJ7 | |
| FKTIGVKIYSFGLGG | 296 | Q99523 | |
| DGAVVKFGQGFGKTN | 116 | Q9H5V9 | |
| LNGGSEKGFGIFVEG | 546 | Q8TEU7 | |
| KKGGIGFKEFENAEG | 56 | Q6ZMQ8 | |
| LKSGDGITFGVFGSK | 91 | O60934 | |
| ISDGRGKVGTFGIFK | 216 | Q92546 | |
| KIGKGSFGEVFKGID | 41 | Q9Y6E0 | |
| GKGSFGEVFKGIDNR | 31 | Q9P289 | |
| EKASGEGFGKTAAII | 126 | Q5VZ19 | |
| KVVGKIYGGRDAAAG | 76 | A8MTI9 | |
| GSGGGGFFESFKRVI | 421 | P47736 | |
| GGFVLLDGETFEVKG | 161 | Q13228 | |
| FTAAGVKPQGKVAGF | 156 | Q96T60 | |
| DFKVGNLLGKGSFAG | 11 | O00444 | |
| EKVGSGGFGQVYKVR | 26 | P57078 | |
| LFGIFVDIGVGKSGL | 931 | Q8N5C6 | |
| FVSENEGALGKGKGK | 126 | Q8TDI8 | |
| DTLGVGTFGKVKVGK | 31 | Q13131 | |
| GEPGEVFINKGKGFG | 321 | P23246 | |
| NKFGGKLGFFGTGEC | 416 | Q9ULP9 | |
| IGNKFLKASVGFGGS | 261 | O60701 | |
| AQKGGAAGFFKGVGK | 2986 | Q96RL7 | |
| AAGFFKGVGKGLVGA | 2991 | Q96RL7 | |
| GEVNFGGSGKKRGKF | 26 | Q9NZQ8 | |
| KDYVKGFGGKFGVQT | 226 | Q14247 | |
| FAPGGGKQKGIVAAF | 536 | P80108 | |
| EGAKKEGAAGFFKGI | 3541 | Q709C8 | |
| EGAAGFFKGIGKGLV | 3546 | Q709C8 | |
| FFKGIGKGLVGAVAR | 3551 | Q709C8 | |
| TGNFKFGDQGGFKIG | 921 | P49790 | |
| GGFAGLFDLKAAGFK | 471 | P22102 | |
| GFKQGAVLFASKAGA | 1191 | Q9BZH6 | |
| GAFGKVVQASAFGIK | 836 | P17948 | |
| HEIIGSGSFGKVYKG | 466 | Q59H18 | |
| AKGRFLKIAEVGAGG | 81 | Q00577 | |
| DGKFSKSRGVGVFGD | 591 | P56192 | |
| GRFLGKGGFAKCFEI | 56 | P53350 |